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SUMMARY 
Streptomycete bacteria are a great source of natural bioactive secondary metabolites, 
some of which are being used as antibiotics and anticancer drugs. Many 
streptomycetes have the genomic potential for producing 20-30 chemically diverse 
bioactive secondary metabolites, while only 2-4 secondary metabolites are produced 
under standard laboratory conditions. Activation of otherwise “silent” gene clusters is 
possible by changing the growth conditions, but detection of new compounds is a 
challenging and time-consuming process. A biosensor that could detect production of 
new compounds would greatly assist in discovering new drugs. 
Many gene clusters for antibiotic biosynthesis contain genes encoding transporters for 
antibiotic efflux, thereby conferring resistance to the antibiotic. Expression of these 
genes is often induced in parallel with antibiotic biosynthesis to avoid intracellular 
accumulation of the toxic compound. A transcriptional biosensor can be constructed 
by fusing the promoter, which controls transporter gene expression, to a reporter gene. 
Expression of the antibiotic may then be detected, since the reporter gene is placed 
under the same regulatory control as the gene encoding an antibiotic efflux pump.  
Streptomyces venezuelae ATCC 10712 (wild type) produces two antibiotics under 
laboratory conditions: chloramphenicol (Cml) and jadomycin B (JadB). This 
bacterium also has 27 other gene clusters encoding secondary metabolites. The genes 
encoding transporters in the Cml gene cluster are most likely expressed in parallel with 
the genes encoding enzymes for Cml biosynthesis. In order to check this hypothesis, 
this Master thesis aims at constructing biosensors by placing a reporter gene (gusA 
encoding β-glucuronidase) under the transcriptional control of two promoters upstream 
of transporter genes (cmlF and kefB) in the Cml gene cluster. A positive control vector 
should be constructed by fusing the strong constitutive ermE* promoter to the reporter 
gene in a similar vector, while the negative control vector has no promoter. 
In order to construct the biosensor plasmids, a vector template (pSOK805), a reporter 
gene (gusA) and different promoters were PCR-amplified to ensure overlapping 
terminal sequences. Ligation of the overlapping DNA fragments was performed by an 
in vitro isothermal reaction, called ‘Gibson’ reaction. The reaction mixes were 
transformed into Escherichia coli strains and plasmid DNA was isolated from the 
transformants. 
The biosensors and control vectors were successfully assembled and verified. Three 
out of four vectors were site-specifically integrated into the genome of S. venezuelae 
by conjugative DNA transfer from E. coli ET12567. In order to test the sensitivity of 
the biosensors, the S. venezuelae recombinant strains were cultured in low-production 
medium with and without addition of ethanol. Samples were collected from the 
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cultures to measure the chloramphenicol production and reporter enzyme activity. One 
of the biosensor strains showed a correlation between chloramphenicol production and 
the enzyme activity, but this trend needs to be verified by further experiments. Only 
small amounts of chloramphenicol were produced by the cells, thus different 
cultivation media should be tested in future experiments. The measurements of 
enzyme activity in the lysates are preliminary, since the protein content has to be 
adjusted to get comparable results. No final conclusions can be drawn on the 
functionality of the biosensors, before several independent experiments are performed. 
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SAMMENDRAG 
Streptomycete bakterier er en god kilde til naturlige bio-aktive sekundære metabolitter, 
hvorav noen blir brukt som antibiotika og kreftmedisiner. Mange streptomyceter har 
genomisk potensial for å produsere 20-30 ulike bio-aktive sekundære metabolitter, 
mens bare 2-4 av disse produseres under standard laboratoriebetingelser. Aktivering av 
"stille" gen-klustre er mulig ved å forandre vekstbetingelsene, men påvisning av nye 
forbindelser er en utfordrende og tidkrevende prosess. En biosensor som kan oppdage 
produksjon av nye forbindelser vil kunne bidra til å oppdage nye legemidler. 
Mange gen-klustre for biosyntese av antibiotika inneholder gener som koder for 
transportører av antibiotika, og som dermed gjør bakterien resistent. Disse genene 
uttrykkes ofte parallelt med biosyntesen av antibiotikumet for å unngå intracellulær 
akkumuleringen av den giftige forbindelsen. En transkripsjonell biosensor kan 
konstrueres ved å fusjonere promotoren som kontrollerer transport genet til et reporter 
gen. Produksjon av antibiotikumet kan dermed oppdages, siden reportergenet er 
plassert under samme regulatoriske kontroll som genet for antibiotika-
transportpumpen. 
Streptomyces venezuelae ATCC 10712 (villtype) produserer to antibiotika-typer under 
laboratoriebetingelser: kloramfenikol (Cml) og jadomycin B (JadB). Denne bakterien 
har også 27 andre gen-klustre som koder for sekundære metabolitter. Genene som 
koder for transportører i Cml klusteret blir sannsynligvis uttrykt parallelt med genene 
som koder for enzymer for Cml biosyntese. For å teste hypotesen, har denne 
masteroppgaven som mål å konstruere biosensorer ved å plassere et reporter gen 
(gusA) under transkripsjonell kontroll av to promotorer oppstrøms for transporter 
gener (cmlF og kefB) i Cml klusteret. En positiv kontroll vektor skal bli konstruert ved 
å fusjonere den konstitutive ermE* promotoren til reportergenet i en lignende vektor, 
mens vektoren for negativ kontroll mangler promotor.  
For å konstruere disse vektorene ble en vektor mal (pSOK805), et reporter gen (gusA) 
og ulike promotorer amplifisert med PCR for å lage overlappende ender. De 
overlappende DNA-fragmentene ble ligert i en in vitro isoterm reaksjon, kalt ‘Gibson’ 
reaksjon. Reaksjonsblandingene ble transformert inn i E. coli-stammer, og plasmid 
DNA ble isolert fra transformantene. 
Biosensorene og kontroll vektorene ble vellykket satt sammen og verifisert. Tre av fire 
vektorer ble integrert i genomet til S. venezuelae ved konjugativ DNA overføring fra 
E. coli ET12567. For å teste sensitiviteten til biosensorene, ble de rekombinante S. 
venezuelae stammene dyrket i et lav-produksjons-medium med og uten tilsats av 
etanol. Det ble tatt prøver fra kulturene for å måle kloramfenikol produksjonen og 
aktiviteten til reporter enzymet. En av biosensor stammene viste en sammenheng 
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mellom kloramfenikol produksjon og enzymaktiviteten, men denne tendensen må 
verifiseres med flere eksperimenter. Kun små mengder av kloramfenikol ble produsert 
av cellene. Derfor bør ulike dyrkingsmedier testes i kommende eksperimenter. 
Målingene av enzymaktivitet i cellelysater er foreløpige, siden proteininnholdet må 
justeres for å få sammenlignbare resultater. Ingen endelige konklusjoner kan trekkes 
angående funksjonaliteten til biosensorene før flere uavhengige eksperimenter er 
utført. 
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dsH2O distilled sterile water 
EHF Expand high fidelity 
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1  INTRODUCTION 
1.1 ACTINOMYCETES 
The actinomycetes are a large group of gram positive bacteria that form branching 
filaments. The network of filaments formed during growth is called mycelium and is 
similar to the mycelium formed by filamentous fungi (Madigan et al., 2009). These 
bacteria live mostly in the soil, but are also found in marine environments such as the 
Trondheim fjord (Bredholdt et al., 2007, Bredholt et al., 2008). Most actinomycetes 
form spores on solid media after nutrient depletion has occured. When the spores are 
transferred to more nutrient-rich environments, they germinate to give rise to new 
colonies. Actinomycetes are considered GC-rich bacteria, since their genomic DNA 
consists of 63-78 % guanine and cytosine.  
Many actinomycetes are able to produce secondary metabolites with diverse biological 
activities. After extensive screening of actinomycetes, many important antibiotics, 
anti-cancer agents and cholesterol-lowering drugs have been discovered in this genera 
(Zotchev et al., 2012). The fact that each actinomycete genome contains approximately 
20-30 gene clusters for biosynthesis of secondary metabolites (Siegl and Luzhetskyy, 
2012) increases the interest for discovering new potential drugs in these bacteria. 
However, only 2-4 of the gene clusters are expressed under laboratory conditions, or 
the compounds are present in too low amounts to be detected. Awakening of these 
silent gene clusters can presumably be achieved by modifying environmental factors 
such as temperature, pH, salinity and signaling molecules (Zotchev, 2012). Several 
other strategies for activation of gene expression will be presented in Chapter 1.4.1. 
1.2 STREPTOMYCETES 
The genus Streptomyces includes gram-positive bacteria belonging to the order 
Actinomycetales. The streptomycetes have GC-rich genomes represented by linear 
chromosomes of 5-11 Mb in size. Most Streptomyces grow in alkaline to neutral soil 
and they are quite versatile when it comes to nutrition. These bacteria can use a wide 
variety of carbon sources, such as sugars, amino acids, alcohols, organic acids and 
aromatic compounds. Many Streptomyces produce and secrete enzymes for hydrolytic 
breakdown of polysaccharides, proteins and lipids (Madigan et al., 2009). 
The Streptomycetes have a complex life cycle which is presented in Figure 1.1. The 
bacteria form a large network of multicellular filaments called mycelium, which is 
similar to fungal growth (Weber et al., 2003). The Streptomyces life cycle begins when 
a spore germinates and continues to grow in a filamentous manner by replication 
without cell division. As the colony ages, aerial filaments are formed and give rise to 
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spores by building up cross-walls in the multinucleate filaments (Madigan et al., 
2009). When the spores mature, they can be spread to more nutrient- rich 
environments. Streptomyces possibly produce antibiotics as a mechanism to inhibit 
growth of organisms competing for the same limiting nutrients. This  increases the 
survival chance for Streptomyces, because it can complete the sporulation process and 
spread to new environments before the nutrients are fully consumed (Madigan et al., 
2009). 
 
Figure 1.1: The life cycle of Streptomyces (Brooks et al., 2012).  
Streptomyces are known to produce a wide variety of secondary metabolites, most of 
which are a great source for new drugs. Over 55 % of the known antibiotics were 
produced by streptomycetes and 11 % by other actinomycetes (Weber et al., 2003). 
This increases the interest for finding new natural drugs by expressing silent secondary 
metabolite gene clusters in these bacteria. 
Antibiotic biosynthesis in Streptomyces depends on the growth phase. In liquid 
culture, antibiotic production begins at the end of the exponential growth phase and as 
the culture enters stationary phase (Kieser et al., 2000).  On solid media, the antibiotic 
biosynthesis coincides with the development of aerial hyphae and continues while 
sporulation occurs (Bibb, 2005). Several physiological and environmental factors 
influence the onset of antibiotic biosynthesis including growth rate, imbalances in 
metabolism, physiological stress and the presence of signaling molecules such as γ-
butyrolactones (GBL) (Kieser et al., 2000). The latter are quorum sensing signaling 
molecules in actinomycetes.  
Streptomyces venezuelae is a gram positive soil bacterium, which grows particularly 
fast under laboratory conditions compared to other streptomycetes. It is known to 
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produce the antibiotics jadomycin B (JadB) and chloramphenicol (Cml), and has 27 
other interesting gene clusters for secondary metabolism. Chloramphenicol 
biosynthesis depends on the presence of nitrogen and glucose in the medium, while 
jadomycin biosynthesis is induced under stress conditions, such as heat shock, phage 
infection or toxic ethanol concentration in the cultivation medium (Doull et al., 1994, 
Yang et al., 1995). The biosynthesis of jadomycin and chloramphenicol were found to 
be coordinated by pseudo-γ-butyrolactone (GBL) receptors which assures that only 
one of the antibiotics is synthesized at any time (Xu et al., 2010b). Most of the 27 
other gene clusters in S. venezuelae are silent under laboratory conditions, but it might 
be possible to trigger expression of otherwise silent gene clusters by using different 
growth media, incubation conditions or signaling molecules. Detection of new 
compounds are, however, very time-consuming and requires advanced analytical 
equipment. A biosensor could be used to detect production of new compounds and 
would be helpful in drug discovery and process development for new antibiotics. 
1.3 ANTIBIOTICS 
The discovery of penicillin by A. Fleming in 1928 has revolutionized the treatment of 
bacterial infections. This antibacterial compound was able to kill a wide range of 
bacteria, and was introduced into medical practice in the early 1940s (Zotchev, 2008). 
Since then, researchers have discovered a huge number of new antibiotics with 
different chemical structures and activities. The “golden era of antibiotics” ended with 
dramatically decreasing discovery of new compounds. At the same time, pathogens are 
developing resistance shortly after introducing a new antibiotic drug into medical 
practice. Now, there is an urgent need to find new antibiotics effective against 
multiresistant life-threatening organisms (e.g. Staphylococcus aureus, Mycobacterium 
tuberculosis and Pseudomonas aeruginosa) (Fischbach and Walsh, 2009). However, 
the big Pharmaceutical companies are no longer developing new antibiotics, because 
of the low profit compared to drugs for treating chronic diseases (Livermore et al., 
2011). New technologies such as screening methods, metabolic engineering and 
synthetic biology can be useful tools to discover new antibiotics in natural 
environments.  
Antibiotics are chemical substances produced by a microorganism that kills or inhibits 
growth of other living organisms (Madigan et al., 2009). These antimicrobial, 
antifungal and/or antiparasitic compounds are used in medical treatment, food industry 
and in research. Several organisms, including bacteria, fungi, plants and animal 
species, are able to synthesize antibiotics. Bacteria and fungi can synthesize 
chemically diverse antibiotics, while plants and animals mostly produce peptides and 
terpenes with antibiotic activity. Over 60 % of all known antibiotic compounds are 
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produced by the order Actinomycetales which are GC-rich, gram positive bacteria 
(Zotchev, 2008).  
Antibiotics are secondary metabolites, which are not required for growth of the 
producing organism. Primary metabolites such as amino acids, sugars and lipids are on 
the other hand necessary for growth and maintenance of the organism. Biosynthesis of 
antibiotics can be divided into two stages. First, the antibiotic scaffold is synthesized 
from primary metabolites, catalyzed by enzymes encoded for by the scaffold assembly 
in Figure 1.2. These antibiotic scaffolds usually possess little or no antimicrobial 
activity. The second stage includes modification of the scaffolds by specific enzymes 
that add functional groups, rendering complete and fully active antibiotic molecules 
(Zotchev, 2008).  
Genes encoding enzymes for antibiotic biosynthesis are arranged in gene clusters and 
their expression is tightly regulated. The organization of a typical gene cluster is 
presented in Figure 1.2. 
 
Figure 1.2: Organization of a typical antibiotic biosynthesis gene cluster (Zotchev, 2008). 
The gene cluster often contains one or more transporter genes encoding efflux pumps 
that export antibiotic molecules out of the cell. These transmembrane transporter 
molecules are important resistance mechanisms for antibiotic producing cells, as well 
as other bacteria that develop resistance (reviewed in (Piddock, 2006, Higgins, 2007)). 
Expression of the transporter has to be activated in parallel with antibiotic production, 
in order to avoid a toxic intracellular antibiotic concentration in the bacteria. The gene 
cluster may also contain resistance genes encoding enzymes that inactivate 
accumulated antibiotics by degradation, modification or changing functional groups on 
the molecule (Zotchev, 2008). Regulatory genes are also important to ensure that 
certain genes are only expressed when needed. These regulatory genes encode 
repressors and/or activators that interact with inducers and/or co-repressors as well as 
operator regions for the genes they regulate (Klug et al., 2009).  
Intracellular antibiotic production represents a metabolic burden to the producing 
organism and is therefore tightly regulated. The biosynthesis can be activated in 
response to certain environmental stimuli such as nutrient depletion, organic solvents, 
changes in pH or temperature, phage infection, presence of signaling molecules or 
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other organisms competing for the same nutrients (reviewed in (Zotchev, 2008)). 
During exponential growth in liquid culture, the primary metabolites are used to build 
up biomass. Biosynthesis of antibiotics and other secondary metabolites are initiated 
when the bacterial growth rate ceases and the cell culture enters the stationary growth 
phase (Wohlleben et al., 2012).  
1.3.1  Chloramphenicol (Cml) 
The antibiotic chloramphenicol (Cml) is a broad-spectrum antibiotic produced by the 
Gram-positive soil bacterium Streptomyces venezuelae and some related species. Cml 
inhibits bacterial growth by binding reversibly to the peptidyl transferase unit of the 
ribosome, thus preventing protein biosynthesis (Pongs, 1979). Almost all gram-
positive and gram-negative bacteria are inhibited by Cml, which became available for 
clinical use in 1948. However, the use of Cml is restricted due to several unusual and 
life threatening toxicity syndromes (Shaw and Leslie, 1989).  
The molecule structure of Cml is shown in Figure 1.3 and seems quite simple 
compared to other antibiotics. Chloramphenicol is derived from the shikimate pathway 
which assembles aromatic metabolites in bacteria (He et al., 2001). The genes 
encoding enzymes for Cml biosynthesis from chorismic acid are situated in a gene 
cluster which is presented in Figure 1.6 later in the introduction.  
 
Figure 1.3: The molecule structure of chloramphenicol (Brooks et al., 2012). 
Chloramphenicol production in S. venezuelae depends on the presence of nitrogen and 
glucose. The activity of Cml biosynthetic enzymes depends on the concentration of 
excess glucose in nitrogen-limited media, and conversely, the glucose-suppression of 
Cml production depends on the residual nitrogen source (Doull and Vining, 1990). 
High yield of Cml was achieved when using a nitrogen source (e.g. DL-Serine) that 
resulted in slow and controlled growth of the bacteria (Westlake et al., 1968). Under 
non-producing conditions, S. venezuelae is relatively sensitive to Cml, but resistance is 
induced by exposure to Cml. Under Cml-producing conditions, the resistance increases 
with Cml biosynthesis (Mosher et al., 1995), indicating that resistance mechanisms are 
induced in parallel with Cml production.  
Some bacteria evolved resistance mechanisms against Cml within few years after its 
introduction into clinical use (Shaw and Leslie, 1989). Resistance to Cml has been 
reported to arise from several different enzymatic modifications, such as 
dehalogenation, nitro group reduction, hydrolysis of the amide bond  and acetylation 
of one or both of the hydroxyls of Cml (Murray and Shaw, 1997). In most eubacteria, 
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resistance is mediated by Cml acetyltransferase which  acetylates the (C-3) hydroxyl 
group, yielding inactive 3’O-acetyl-Cml (Mosher et al., 1995).  
Bacteria have also acquired resistance against Cml by specific and/or multidrug 
transporters (reviewed in (Schwarz et al., 2004)). One multidrug transporter called 
Mdfa has been identified in E. coli, and overexpression of Mdfa made E. coli resistant 
to many antobiotics, including Cml. However, deletion of the mdfa gene barely 
influenced the cellular resistance, and the real physiological role of Mdfa was found to 
be a Na
+
(K
+
)/H
+
 antiporter, which ensures constant intracellular pH under alkaline 
conditions (reviewed in (Higgins, 2007)). 
Interestingly, the Cml producer S. venezuelae has developed its own resistance 
mechanism which includes phosphorylation of the (C-3) hydroxyl group by Cml 
phosphotransferase (CPT). It is suggested that CPT acts as a carrier that facilitates 
export of the phosphorylated Cml to an efflux pump. The transmembrane transporter 
protein then exports Cml-3’-phosphate out of the cell, and the protective phosphate 
group is removed by an extracellular phosphatase, releasing active Cml to the 
environment (Izard, 2001). Expression of the transporter protein is presumed to be 
tightly regulated and will be explained further in Chapter 1.7-1.8. 
1.4 SYNTHETIC BIOLOGY: A TOOL FOR DRUG DISCOVERY 
A group of European experts proposed the following definition of synthetic biology: 
“Synthetic biology is the engineering of biology: the synthesis of complex, 
biologically based (or inspired) systems, which display functions that do not exist in 
nature” (Serrano, 2007). Synthetic biology brings together engineering and biology to 
design novel biological devices from natural parts such as genes, promoters, operators, 
terminators, vectors etc. The well-characterized parts can be combined in a new way to 
create systems that function in a predictable manner (reviewed in (Neumann and 
Neumann-Staubitz, 2010)). Synthetic biology is used to reorganize genomes and for 
improved design of biochemical pathways for the commercial production of desired 
products. It also has many applications in biosensing, therapeutics, production of 
biofuels, pharmaceuticals and novel biomaterials (Khalil and Collins, 2010). Synthetic 
biology is a means to make orthogonal biological systems, explore transcriptional 
regulation and detect certain environmental compounds. The aim of synthetic biology 
is to control cellular behavior by applying engineering tools and use characterized 
parts to achieve desired functions (Mukherji and van Oudenaarden, 2009).  
It is complicated and challenging to engineer cells because of intracellular “noise” in 
the stochastic regime (reviewed in (Andrianantoandro et al., 2006)). Cellular activities 
have to be seen as random and based on probability, thus most genetic interactions are 
stochastic and not deterministic when few molecules are involved. Quorum sensing 
molecules can circumvent the challenges with cell control to make cells react in 
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synchrony to an induction signal. Good examples of this are construction of pulse 
generating cells (Basu et al., 2004) and synchronized oscillating cells (Danino et al., 
2010). They report on two different systems in synthetic circuits that express the GFP 
(green fluorescent protein) reporter in a pulse and oscillatory manner, respectively.  
The biological devices and synthetic circuits are introduced into ‘chassis’, which is an 
engineered organism that ensures optimal performance of the device. These special 
strains can, for instance, have a reduced genome and reduced number of networks 
which makes it less complex and less “noisy” in expressing the device (reviewed in 
(Heinemann and Panke, 2006)). The super-host cell should be able to recognize the 
promoters and operators used in the devices, as well as detect and respond to induction 
signals.  
1.5 SYNTHETIC BIOLOGY IN STREPTOMYCES BACTERIA 
Whole genome sequencing of Streptomyces species followed by antiSMASH 
(antibiotics & Secondary Metabolite Analysis Shell) has revealed multiple gene 
clusters governing biosynthesis of secondary metabolites. The software antiSMASH 
can rapidly identify and analyze interesting gene clusters in bacterial and fungal 
genome sequences by detecting known classes of secondary metabolite gene clusters 
and compare the evolutionary similarities (Medema et al., 2011a). However, most of 
the detected gene clusters for secondary metabolite biosynthesis are silent or ‘cryptic’ 
pathways which are not expressed under laboratory growth conditions.  
1.5.1  Activation of silent gene clusters 
Silent gene clusters can potentially be expressed by using synthetic biology tools, such 
as reengineering of the regulatory mechanisms. The native regulation system can be 
replaced by a synthetic regulation that is predictable, easy to manipulate and possible 
to fine-tune for the desired function (Medema et al., 2011b). A completely redesign of 
the gene cluster by changing promoters, ribosome binding sites and possibly also the 
codon usage, may be necessary in order to achieve this.  
One strategy for activating silent gene clusters in Streptomyces species is to 
manipulate the regulatory genes, either by modifying the global regulators or alter the 
pathway-specific regulators of secondary metabolism (Zerikly and Challis, 2009). It 
was recently discovered that cyclic AMP receptor protein (Crp), which is known to 
regulate catabolite repression in E. coli, is a global regulator for antibiotic production 
in Streptomyces (Gao et al., 2012). Overexpression of Crp in several Streptomyces 
species increased antibiotic biosynthesis and led to production of new metabolites, 
while deletion of crp in S. coelicolor resulted in dramatic reduction of antibiotic 
production levels.  
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Expression of a silent gene cluster has also been achieved by placing a pathway-
specific positive regulator under the control of a strong constitutive promoter, such as 
ermE*p (reviewed in (Baltz, 2010)). The ermE* promoter could also be inserted in 
front of transporter genes, to avoid toxic accumulation of the antibiotic due to lack of 
transporter capacity at high production levels. This constitutive ermE promoter was 
originally found in front of the erythromycin resistance gene in Saccharopolyspora 
erythraea. One base pair mutation was introduced, resulting in the ermE* promoter 
with enhanced promoter activity (reviewed in (Medema et al., 2011b)). Another 
approach for expressing cryptic gene clusters is to delete a pathway-specific repressor. 
This was performed with a γ-butyrolactone receptor in S. coelicolor and resulted in the 
discovery of a novel bioactive compound (Gottelt et al., 2010).  
When expression of a silent gene cluster has been achieved, the remaining task is to 
isolate the novel compound and elucidate its chemical structure. This depends on 
sufficient yield of the compound and is often a time-consuming process. It would be 
very helpful to have a biosensor that expresses a reporter gene when the silent gene 
cluster is activated and a compound produced. Presence of the reporter can be 
quantitatively detected and shall ideally indicate the amount of produced secondary 
metabolite. 
1.5.2  Expression of secondary metabolites in heterologous hosts 
Expression of secondary metabolite gene clusters can be performed by cloning the 
gene clusters into heterologous hosts suitable for expressing otherwise silent pathways. 
Useful Streptomyces and Saccharopolyspora host strains have been reviewed by Baltz 
(2010). Manipulation of host strains by elimination or silencing of major secondary 
metabolite gene clusters prevents the channeling of precursors into competing 
pathways, thereby improving the yield of the desired product. Such genome-
minimized production hosts only waste a minimal amount of resources for cell 
maintenance, so more of the nutrients are used for production of the desired compound 
(Medema et al., 2011c). Another advantage is that it simplifies the identification of 
novel products from cloned heterologous gene clusters (Baltz, 2010). Different species 
can have different sigma-factors and 16S rRNA sequences, which affect transcription 
and translation of foreign genes. Therefore, it may be necessary to replace the original 
promoter and Shine-Dalgarno sequences in the gene cluster in order to achieve 
successful heterologous expression in a host cell. This replacement can be performed 
by synthetic biology tools and methods for DNA assembly (reviewed in (Zotchev et 
al., 2012, Hillson, 2011)). The ideal host cell for heterologous gene expression in 
Streptomyces should have the following features: be genetically tractable (with several 
vectors and selection markers available), have all (active) secondary metabolite 
biosynthesis gene clusters deleted, have controllable pathways for biosynthesis of 
secondary metabolite precursors, be able to utilize a variety of cheap nutrients, have 
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secondary metabolism independent of growth phase and grow fast without a loss of 
productivity (Zotchev et al., 2012).  
Several factors influence the expression of secondary metabolites both in heterologous 
hosts and in the native strain. It is important that the precursor pools are sufficient 
when expression of the secondary metabolites is induced. During constitutive 
expression, the metabolic requirements for production are competing with the 
pathways necessary for cellular growth and survival. A synthetic regulatory system 
can optimize the timing of enzyme production to ensure that the limiting resources are 
distributed to the right pathways for optimal production of secondary metabolites at 
the right time (reviewed in (Medema et al., 2011c)). It may be advantageous to induce 
expression of secondary metabolite biosynthesis pathways when the biomass is high 
and the growth rate is slowing down, just like the natural induction occurs in 
Streptomyces bacteria. Ideally, the cells should switch to secondary metabolite 
production before nutrient depletion at the end of the exponential growth phase, so that 
high-level production can be coupled to slow growth for maintaining the biomass 
levels.  
Other bottlenecks include enzyme concentrations, enzyme affinity for substrates and 
diffusion of metabolites between the enzymes. These problems can be overcome by 
synthetic protein scaffolds, which assemble proteins into complexes, thus increasing 
the local enzyme concentrations. This strategy prevents the build-up of intermediates, 
increases the metabolic flux through the biosynthetic pathways and results in higher 
product yield (reviewed in (Medema et al., 2011c)). Fine-tuning of enzyme expression 
in a pathway is important to optimize flux and avoid accumulation of toxic 
intermediates. This can be achieved by using synthetic promoters of varying strengths 
and fuse them to the genes encoding enzymes in the pathway (reviewed in (Neumann 
and Neumann-Staubitz, 2010). 
1.5.3  DNA transfer into Streptomyces species 
Plasmid DNA (pDNA) can be introduced into Streptomyces by transformation, 
transfection, electroporation or conjugation. DNA transfer by conjugation is simple 
and usually more efficient than transformation. Depending on the vector used, 
conjugation can result in autonomous replication of the recombinant plasmid, site-
specific integration into the Streptomyces genome or integration via homologous 
recombination between cloned DNA and the Streptomyces chromosome (Kieser et al., 
2000, Bierman et al., 1992). Conjugative transfer occurs in the early growth phase 
when Streptomyces grows as mycelium, and it only takes place on solid media. When 
first introduced into one mycelial compartment, the plasmid is soon transferred to all 
of the mycelial compartments through a protein pore in the crosswalls. This results in 
stable maintenance of the plasmid during vegetative growth and morphological 
differentiation. The mechanism for conjugative transfer in Streptomyces differs from 
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the known mechanism for gram-negative bacteria, which involves pili to establish cell-
to-cell contact and rolling-circle replication to transfer single-stranded pDNA 
(Madigan et al., 2009). In Streptomyces, the mycelial tips grow together and the 
conjugal DNA transfer is mediated by a plasmid-encoded DNA translocator, which is 
a membrane-associated protein localized at the hyphal tip of Streptomyces mycelium. 
This protein is an ATPase that transfers an unprocessed double-stranded DNA 
molecule into the recipient by ATP hydrolysis (Reuther et al., 2006). 
The conjugation method used during this project is based on shuttle vectors that are 
able to replicate in E. coli and integrate site-specifically into the Streptomyces genome. 
The finished constructs are first transferred to the methylation deficient Escherichia 
coli ET12567 strain, which carries a helper plasmid (pUZ8002) that provides transfer 
function from RP4 origin of transfer (oriT). The transformed ET cells are then plated 
out together with heat-shocked Streptomyces spores, since conjugation only takes 
place on solid media. E. coli ET12567 transfers the pDNA containing oriT into S. 
venezuelae, while the helper plasmid is not transferred (Flett et al., 1997). Once the 
constructs are introduced into the recipient, the bacteriophage VWB integrase gene 
(int) and VWB attachment site (attP) are responsible for the site-specific integration of 
pDNA into the Streptomyces genome. Plasmids containing int and attP from the VWB 
phage have been shown to integrate into the host chromosome by recombination with 
the chromosomal attB locus, which is situated within an arginine tRNA gene (Van 
Mellaert et al., 1998). This recombination event between attP (phage attachment site) 
and attB (bacterial attachment site) results in two new sites called attL and attR, as 
shown in Figure 1.4. 
 
Figure 1.4: Integration of pDNA into chromosomal DNA by recombination between attP (POP) 
and attB (BOB) sites, resulting in formation of attL (BOP) and attR (POB) sites (Myronovskyi 
and Luzhetskyy, 2013). 
Crossover between the attP site in the VWB-based vector and the attB site inside the 
Streptomyces genome is only possible in the presence of integrase. The VWB 
integrase belongs to the family of tyrosine recombinases, which recognize the different 
attachment sites even though they show limited similarity (Myronovskyi and 
Luzhetskyy, 2013). Tyrosine recombinase recognizes and binds to the specific 
attachments sites where it catalyzes cleavage, strand exchange and rejoining of the 
DNA fragments (Grindley et al., 2006).  
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1.6 BIOSENSORS 
One practical application of synthetic biology is to construct biosensors for detection 
of specific compounds, screening for new drugs and analyze under which conditions a 
certain gene is expressed and a compound produced. Biosensors are devices that use 
biological receptors to detect certain signals, and respond by giving a measurable 
output. Most biosensors consist of two basic parts: a sensory element that detects and 
recognizes a certain (signal) molecule, and a transducer module that transmits and 
reports the signals. Cells have several regulatory circuits, including transcription, 
translation and post-translational mechanisms, for sensing and responding to 
environmental signals (reviewed in (Khalil and Collins, 2010)).  
Transcriptional biosensors are constructed by fusing environment-responsive 
promoters to a reporter gene. Expression of the reporter gene is in this way controlled 
by a specific promoter, and reporter product can be quantitatively detected if the 
expression from this particular promoter is induced. The most commonly used 
reporters for actinomycetes are green fluorescent protein (GFP) and luciferase. GFP 
can be detected in real time in living cells and organisms simply by UV-light 
excitation. The advantage with GFP reporter is that no substrate is required, and the 
reporter protein is stable. However, GFP has low sensitivity due to background 
fluorescence of materials used in assays and because autofluorescence often can be 
observed in actinomycetes. This makes the analysis complicated due to a low signal-
to-noise ratio (Myronovskyi et al., 2011). 
Whole-cell biosensors are used to detect bioactive compounds in environmental 
samples (Hansen et al., 2001) and to screen for bioactive compounds interfering with 
major biosynthetic pathways in bacteria (Urban et al., 2007). A biosensor strain has 
been developed by fusing an inducible promoter to the luciferase (luxCDABE) operon 
of Vibrio fischeri. This biosensor responded to the presence of antibiotics with a 
certain core structure (macrolides) by expressing the luciferase operon, resulting in 
light emission from the cells. A suitable application of this biosensor strain is to find 
new producers of known macrolides or producers of new macrolide core structures, 
which can result in the discovery of new antibiotics (Möhrle et al., 2007). 
The advantage with biosensors is that they can detect compounds even at small 
concentrations or verify their presence when no standard laboratory procedure for 
isolation, purification and verification of the compound exists. They are also 
particularly useful when the compound structure and function is unknown. The 
biosensor can detect when a certain gene is expressed if the reporter and the desired 
gene are placed under the same regulatory control. Thus, the genes will be expressed 
in parallel by the same induction mechanisms. 
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1.7 REGULATION OF ANTIBIOTIC EFFLUX PUMPS 
Bacteria have developed many mechanisms to sense and respond to environmental 
signals and varying growth conditions. These adaptive responses are mostly mediated 
by transcriptional regulators which provide control over gene expression. Members of 
the TetR- family regulatory proteins control genes encoding products that give 
multidrug resistance and genes for biosynthesis of antibiotics (reviewed in (Ramos et 
al., 2005)). These repressors are important in antibiotic producing bacteria because 
they regulate the expression of antibiotic efflux pumps. Antibiotic efflux is only 
needed when antibiotic compounds accumulate intracellularly, either by diffusing into 
the cell or by antibiotic biosynthesis.  
The TetR repressor in E. coli controls expression of the tetA gene, which encodes an 
antiporter efflux pump that transports tetracycline out of the cell. This regulatory 
network is presented in Figure 1.5. When no tetracycline is present in the cell, the 
TetR repressor is bound to the operator regions for tetA and tetR, thereby inhibiting 
expression of tetA by blocking for RNA polymerase. Expression of the repressor gene, 
tetR, is only slightly reduced when TetR is bound to its operator region. When 
tetracycline (Tc) is present in the cytosol, it interacts with the C-terminal domain of 
TetR, preventing DNA binding and thereby activating expression of the tetA resistance 
gene (Tahlan et al., 2008). The tetA gene will then be expressed and the transporter 
protein becomes integrated into the cell membrane where it starts to pump tetracycline 
out of the cell. After a while, most of the intracellular tetracycline is removed from the 
cell and the remaining Tc will diffuse from the TetR repressor, which then can block 
the tetA operator. This results in fewer transmembrane transporters, because they will 
be degraded after a while and the synthesis of new TetA molecules has stopped.  
 
Figure 1.5: Regulation of tetA expression by the TetR repressor in E. coli. TetA is a 
transmembrane protein that transports tetracycline (Tc) out of the cell. Tetracycline acts as an 
inducer by binding to TetR and inhibiting its repression of the tetA and tetR genes (Ramos et al., 
2005). 
Several TetR-like regulators are present in different bacteria. ActR is a TetR-like 
protein in S. coelicolor which controls the expression of two actinorhodin exporters. 
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Many ligands, including the antibiotic actinorhodin, can bind to ActR and prevent its 
interaction with DNA, thereby inducing expression of antibiotic efflux pumps. This 
indicates that the actR locus can be activated by, and maybe evolved to confer 
resistance to other antibiotics (Tahlan et al., 2008).  
1.8 PROJECT BACKGROUND AND IDEA 
1.8.1  The Chloramphenicol cluster in S. venezuelae 
The S. venezuelae genome contains 29 gene clusters for secondary metabolite 
biosynthesis, but most of them are silent under laboratory conditions. Only the gene 
clusters for biosynthesis of chloramphenicol (Cml) and jadomycin B (JadB) are 
expressed under laboratory conditions. The cluster for Cml biosynthesis is shown in 
Figure 1.6, and contains among others, genes encoding enzymes for Cml biosynthesis 
(cmlD-cmlS) (Piraee et al., 2004). Chloramphenicol biosynthesis starts from Chorismic 
acid which is made in the shikimate pathway. The cmlE gene encodes an enzyme that 
initiates the shikimate pathway and may therefore have a role in regulating this 
pathway to make precursors for Cml (He et al., 2001).  
 
Figure 1.6: The chloramphenicol gene cluster contains genes encoding transporter proteins 
(cmlF, kefB) and enzymes for biosynthesis of chloramphenicol (cmlD-cmlS).  
The amino acid sequence of the cmlF gene was analyzed in BLASTP by He et al. 
(2001). They showed that the sequence was strikingly similar to proteins encoded by 
Cml efflux genes in three other bacteria and the product of cmlV, which is located in 
another region of the S. venezuelae genome than the Cml gene cluster. By topological 
analysis of the CmlF product, they also showed that the protein contained 12-13 
transmembrane domains similar to other Cml efflux proteins. These similarities 
suggest that the cmlF gene encodes a Cml efflux pump that releases the antibiotic into 
the environment and protects the cell from intracellular accumulation of this toxic 
compound (He et al., 2001). The CmlF transporter belongs to the major facilitator 
superfamily (MFS) of multidrug-resistance efflux pumps. Previous research has 
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demonstrated that Cml production in S. venezuelae was only marginally affected by 
disrupting the cmlF gene (He et al., 2001). This indicates the presence of other genes 
mediating Cml efflux or conferring resistance to Cml by inactivating the antibiotic. 
One reported resistance mechanism in S. venezuelae includes phosphorylation of 
chloramphenicol by Cml phosphotransferase (CPT), which also binds its product and 
transports it to the efflux pump (Izard, 2001).  
The promoter sequence of the cmlF gene is divergent with the promoter for the kefB 
gene on the complementary strand. It is possible that these genes are controlled by the 
same regulatory mechanisms. The kefB gene is homologous to transmembrane Na
+
 or 
K
+
 antiporters in other organisms, but the same function is not verified for this gene in 
S. venezuelae. As mentioned previously in Chapter 1.3.1, the Mdfa multidrug 
transporter found in E. coli turned out to be a Na
+
(K
+
)/H
+
 antiporter (reviewed in 
(Higgins, 2007)), so it remains to investigate whether KefB also can have several 
physiological roles in S. venezuelae. It is unknown under which conditions the kefB 
gene is expressed and whether it is coupled to expression of Cml. It would be 
interesting to explore how these two promoters are regulated, thus each promoter will 
be used in biosensor constructs. 
Since genes encoding biosynthetic enzymes and transporter proteins have to be 
expressed in parallel to avoid toxic intracellular accumulation of antibiotics, these 
genes may be regulated by the same protein. It is therefore possible that expression of 
the CmlF and KefB transporters is regulated by a TetR-like protein, possibly (JadR2 
through JadR1) from the JadB gene cluster. This regulation is explained in Chapter 
1.8.4.  
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1.8.2  Regulation of JadB biosynthesis in S. venezuelae 
Two distinct antibiotics are produced in S. venezuelae under different conditions. Cml 
production depends on the presence of nitrogen and glucose, while JadB is produced 
under stress conditions, such as addition of ethanol in the growth medium, heat shock 
or the presence of bacteriophage. The production of these two antibiotics is regulated 
by a pair of regulators situated in the jadomycin gene cluster.  
JadB production is regulated by the TetR-like repressor JadR2 (Yang et al., 1995) and 
by the JadR1 activator (Yang et al., 2001). The JadR1 activator seems to be required for 
jadomycin B production, but it is not expressed in the wild type strain under unstressed 
conditions, possibly due to repression by JadR2. These regulatory interactions between 
JadR1 and JadR2 are presented in Figure 1.7. The JadR2 protein is a TetR-like repressor 
(and a “pseudo” GBL-receptor) that recognizes and binds to the operator upstream of 
the jadR1 gene, which encodes an activator for JadB biosynthesis genes. In that way, 
JadR2 indirectly represses JadB production by inhibiting expression of the JadR1 
activator which is required for JadB biosynthesis.  
 
Figure 1.7: The TetR-like repressor JadR2 in Streptomyces venezuelae regulates the expression of 
Jadomycin B biosynthesis genes by controlling expression of the jadR1 gene. JadR1 acts as an 
activator for jadomycin B biosynthesis (Ramos et al., 2005). 
 
1.8.3  γ-butyrolactone signaling molecules 
Secondary metabolite biosynthesis in Streptomyces is often regulated by small 
signaling molecules called γ-butyrolactones (GBL), which can bind to cytoplasmic 
receptor proteins (reviewed in (Takano, 2006)). These GBL receptors often act as 
repressors by binding to operator regions and thereby inhibiting transcription of certain 
genes. When the diffusible GBL molecules bind to their respective receptors, gene 
expression is induced because the repressor can no longer bind to its operator site. The 
GBL-receptor is a regulatory protein that responds to external signals (GBL-
molecules) and regulates genes encoding pathway-specific regulatory genes for 
antibiotic biosynthesis, collectively known as SARPs (Streptomyces antibiotic 
regulatory proteins), most of which are activators. This cascade of regulatory networks 
16 
 
may be different even for antibiotics with similar structure, because the regulatory 
mechanisms are more diverse than biosynthetic genes (Martín and Liras, 2010).  
It has been speculated whether the GBLs act as quorum sensing molecules like the 
homoserine lactone autoinducers in Gram-negative bacteria (reviewed in (Bibb, 
2005)). Quorum sensing is the cellular response to bacterial population density, which 
is detected by production and recognition of autoinducer molecules. When a high 
concentration of autoinducers is present in a population, they bind to receptors which 
activate the transcription of specific genes. However, the GBLs in Streptomyces are 
not only a communication method between members of the same species or an 
indication of the population density. The interaction between GBL signals and their 
respective receptors influences both antibiotic biosynthesis and sporulation, and 
perhaps they have a role in coordinating both secondary metabolism and 
morphological differentiation during the developing mycelial colony (Bibb, 2005). In 
S. venezuelae, one gene (jadW1) found in the JadB gene cluster, is associated with 
production of GBL signaling molecules and was shown to control sporulation and 
antibiotic production (Wang and Vining, 2003). The jadW1 component in the GBL 
system probably acts as a positive regulator for cellular differentiation, while the 
mechanism of influencing GBL synthesis is unknown. 
 
1.8.4  Cross-regulation of JadB and Cml biosynthesis in S. venezuelae 
Some antibiotics in sub-inhibitory concentrations have a general signaling role to 
induce changes in gene transcription in a bacterial population. The mechanisms by 
which they act are not completely revealed yet, but Xu et al. (2010b) demonstrated that 
antibiotics can act as signaling molecules just like the quorum sensing auto-inducers. 
Unlike usual GBL receptors, which only bind specific GBL molecules, “pseudo”-GBL 
receptors, such as JadR2, coordinate antibiotic biosynthesis by binding and responding 
to different antibiotics. In S. venezuelae, JadR2 was found to bind jadomycin A and B, 
which led to its dissociation from the jadR1 promoter. Cml was, however, less 
effective than jadomycin A and B in inhibiting the DNA-binding properties of JadR2 
(Xu et al., 2010b).   
The Cml biosynthetic gene cluster in Streptomyces venezuelae (Figure 1.6) has no 
cluster-situated regulators, so Xu et al. (2010b) investigated whether JadR2 also 
regulates the Cml biosynthesis. They demonstrated that JadR2 is a GBL receptor 
homologue in S. venezuelae that coordinates Cml and JadB biosynthesis by direct 
repression of jadR1 expression. JadR2 was found to indirectly activate chloramphenicol 
biosynthesis by inhibiting expression of jadR1, which represses Cml production. The 
JadR1 was shown to directly regulate both JadB and Cml biosynthetic pathways as 
shown in Figure 1.8.  
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Figure 1.8: Coordination of chloramphenicol (Cml) and jadomycin B (JadB) biosynthesis by the 
pseudo γ- butyrolactone (GBL) receptor JadR2 which represses the transcription of jadR1. The 
cluster situated regulator JadR1 activates the biosynthesis of JadB and represses the Cml 
biosynthetic genes (Xu et al., 2010b). 
In the regulatory network of JadB and Cml biosynthesis, JadR2 is the signal 
coordinator that senses metabolites and responds by regulating the transcription of 
jadR1, which directly controls the antibiotic biosynthesis (Xu et al., 2010b). JadB was 
found to feedback regulate its own biosynthesis by interacting with JadR1 (Wang et al., 
2009). The “pseudo” GBL receptor JadR2 could bind to Cml and JadB, and the 
interactions led to derepression of jadR1, thus inducing expression of this cluster-
situated regulator (Xu et al., 2010b). This feedback control is a mechanism for tight 
regulation and coordination of antibiotic biosynthesis, which ensures that only one of 
the two antibiotics, JadB or Cml, is synthesized at any time.  
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1.8.5  The aim of this Master thesis 
Expression of genes encoding transporters for chloramphenicol (Cml) efflux is most 
likely induced in parallel with the genes encoding enzymes for Cml biosynthesis. In 
order to check this hypothesis, this Master thesis aims at constructing biosensors by 
placing a reporter gene under transcriptional control of the cmlF and kefB promoters. If 
the hypothesis is correct, the reporter gene will be expressed under Cml-producing 
conditions, and will be repressed when Cml-production is inhibited by addition of 
ethanol.  
The project idea is illustrated in Figure 1.9. Promoters from the Cml cluster in S. 
venezuelae will be combined with a vector and a reporter gene to construct biosensor 
plasmids. A positive and a negative control plasmid will also be made to make sure 
that the results from the reporter assay are not random. These constructs are shuttle 
vectors that can replicate in E. coli strains and provide site-specific integration into the 
genome of S. venezuelae. The recombinant S. venezuelae strains will be grown under 
different conditions, and expression of the reporter gene will be analyzed by 
performing reporter assays as described in Chapter 1.9.2. Cml production will be 
measured by Ultra high Performance Liquid Chromatography (UPLC) analysis in 
parallel with the reporter assay. 
  
Figure 1.9: The project aims at constructing biosensor plasmids based on a shuttle vector, 
promoters from the chloramphenicol cluster and a reporter gene. These biosensors will be 
introduced into S. venezuelae and then reporter expression will be analyzed under different 
conditions by performing reporter assays. 
The plasmids are constructed as model biosensors which principle of operation, if 
proven functional, can be used for analysis of other interesting gene clusters in 
Streptomyces. If the biosensors function as predicted, other promoters for efflux pump 
expression in silent gene clusters can be introduced into new biosensors. Then it may 
be easier to check under which conditions a silent secondary metabolite gene cluster is 
expressed. This can be a useful strategy to discover new drugs in Streptomyces, which 
are important sources for bioactive secondary metabolites.  
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1.9 METHODS TO BE EMPLOYED 
1.9.1  DNA assembly method (‘Gibson’ reaction) 
Methods for DNA assembly are important tools in synthetic biology. These techniques 
enable the reconstruction of natural pathways as well as combination of individual 
parts to create new genetic circuits with predictable properties. Modern DNA assembly 
techniques can be divided into methods that use restriction enzymes such as Golden 
Gate and Bio Brick, and the sequence independent protocols such as Gibson 
isothermal assembly and SLIC (Sequence and Ligase Independent Cloning) (reviewed 
in (Zotchev et al., 2012)). Recently, a novel cloning method called SLiCE (Seamless 
Ligation Cloning Extract) was reported to assemble several DNA fragments in a single 
in vitro reaction involving bacterial cell extract (Zhang et al., 2012). 
In this work, DNA fragments are joined by the so-called ‘Gibson’ reaction, described 
by Gibson et al. (2009). They combined several linear DNA molecules with 
overlapping terminal sequences in a one-step isothermal reaction. The DNA fragments 
are added in equimolar amounts to a mix containing three enzymes, and this mix is 
incubated at 50 °C for one hour. The enzyme T5 exonuclease removes nucleotides 
from the 5´ends of double stranded DNA, leaving the complementary sequences open 
for annealing. Incubation at 50 °C inactivates the heat-labile T5 exonuclease after a 
while, and the overlapping fragments can anneal. Finally, Phusion polymerase will 
introduce nucleotides in the gap and Taq ligase seals the nicks, resulting in a seamless 
DNA molecule. This ‘Gibson’ reaction is described in Figure 1.10. 
 
Figure 1.10: One-step isothermal in vitro recombination. DNA fragments with terminal sequence 
overlaps (black) were joined into one molecule in a one-step reaction. Three enzymes contribute 
to the reaction. T5 exonuclease chews back nucleotides from the 5´ends of double stranded DNA 
molecules until the enzyme is inactivated. The complementary single-stranded DNA anneal, 
Phusion DNA polymerase filles the gaps with nucleotides and Taq DNA ligase seals the nicks 
(Gibson et al., 2009). 
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1.9.2  Reporter assay 
Ideal reporter assays are sensitive, quantitative, reproducible, easy, rapid and safe 
(reviewed by (Schenborn and Groskreutz, 1999)). The most commonly used reporters 
for actinomycetes are GFP and luciferase. However, the GFP reporter gene is not ideal 
for actinomycetes, because of low sensitivity. The luciferase assays are not optimal 
either, due to the complexity of enzymatic reactions, which require multiple reagents. 
In addition, the transcriptional level cannot be quantitatively detected because there is 
no enzymatic amplification of the light emitting signal (Myronovskyi et al., 2011). 
In this project, the reporter gene gusA encoding β-Glucuronidase (GUS) will be used 
in the biosensors. Using GUS as a reporter has many advantages: it is highly sensitive, 
stable and offers high specific enzyme activity without any cofactors. In addition, the 
enzyme is tolerant to commonly used chemicals and assay conditions, and most 
streptomycetes do not possess any endogenous GUS activity. The GUS reporter assay 
is simple, sensitive and inexpensive with many available substrates for different types 
of assays (Myronovskyi et al., 2011). A spectrophotometric assay will be used in this 
project, but the GUS assay can also be fluorometric and chemiluminescent, depending 
on the substrate. The substrate for analyzing expression of gusA in this project is p-
nitrophenyl-β-D-glucuronide (PNPG). The GusA enzyme cleaves PNPG, yielding β-
D-glucuronic acid and p-nitrophenol as described in Figure 1.11. The latter is a 
chromogenic compound that has a maximum absorbance at 405 nm (Aich et al., 2001).  
 
Figure 1.11: The GusA reporter assay. If the gusA gene is expressed in one of the biosensor 
constructs, the GusA enzyme will catalyze the reaction from p-nitrophenyl-β-D-glucuronide 
(PNPG) to β-D-glucuronic acid and p-nitrophenol, which has a maximum absorbance at 405 nm. 
  
21 
 
2  MATERIALS AND METHODS 
2.1 CHEMICALS AND EQUIPMENT 
The chemicals and laboratory equipment that were utilized are given in Table 2.1.1 
and 2.1.2, respectively. 
Table 2.1.1: Chemicals and enzymes used for the laboratory work. 
Chemicals Producer 
AatII New England Biolabs Inc. 
Acetic Acid SdS 
Agar Bacteriological OXOID LTD 
Ampicillin sodium salt BioChemica, AppliChem 
BSA New England Biolabs Inc. 
Chloramphenicol AppliChem 
Difco ISP Medium 4 Becton, Dickinson and Company 
DMSO Sigma-Aldrich 
dNTP’s Promega 
DpnI New England Biolabs Inc. 
DTT (Dithiothreitol)  VWR 
EcoO109I New England Biolabs Inc. 
EDTA (0.5 M) Merck 
Ethanol (96 %) VWR 
Ethyl acetate HiPerSolv Chromanorm for HPLC VWR 
Expand High Fidelity (EHF) DNA polymerase Roche 
GC-rich PCR buffer Roche 
GC-rich resolution solution Roche 
GelGreen Nucleic Acid Stain (10 000x) (Cat: 41005) Biotium 
Gene ruler™ DNA ladder mix (Lot. 2702) Fermentas 
Glycerol bidistillied (99.5 %) AnalaR NORMAPUR, VWR Prolab 
High Fidelity 2x Long PCR premixes (1-9) Epicentre 
Isopropanol Arcus 
Kanamycin AppliChem 
Lysozyme (> 30 000 FIP U/mg) Merck 
Malt extract Sigma-Aldrich 
Maltose (Lot 109H1049) Sigma-Aldrich 
MasterAmp Extra-Long DNA Pol. Mix  (2.5 U/µl) Epicentre 
Methanol LC-MS Chromasolv (> 99.9 %) Sigma-Aldrich 
MgCl2  (25mM) Roche 
MOPS sodium salt (99 %) AppliChem 
NaCl VWR 
Na2HPO4 * 2H2O (99.5 %) Merck 
NAD (100 mM) Sigma-Aldrich 
NaH2PO4 *H2O (99.0 %) Merck 
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Chemicals Producer 
Nalidixic acid sodium salt Sigma-Aldrich 
NaOH (99 %) Merck 
NEB buffer 3 and 4 New England Biolabs Inc. 
Phusion HF DNA polymerase (2 000 U/ml) New England Biolabs Inc. 
p-nitrophenyl-β-D-glucuronide (PNPG) (99.4 %) CalbioChem  
Polyethyleneglycol (PEG8000) FLUKA 
Primers (Attachment C) Sigma-Aldrich 
PstI New England Biolabs Inc. 
SeaKem LE Agarose (Catalog no. 50004) Cambrex Bio Science Rockland, Inc. 
T5 exonuclease (10 U/µl) New England Biolabs Inc. 
Taq DNA ligase (40 000 U/ml) New England Biolabs Inc. 
Thiostrepton from Streptomyces aureus (min. 90 % HPLC) Sigma-Aldrich 
Tris-base Roth 
Triton X-100 SigmaUltra Sigma-Aldrich  
Tryptone OXOID LTD 
Tryptone soya broth (TSB) OXOID LTD 
XmaI New England Biolabs Inc. 
Yeast extract OXOID LTD 
Table 2.1.2: Equipment used in the laboratory. 
Equipment Specification Producer 
Autoclave SX-500E Tomy 
Cryo vials   Greiner bio-one 
Cyvettes (0.1 cm gap) Bio-Rad 
DNA gel electrophoresis power source Power PAC Bio-Rad 
DNA gel electrophoresis systems Owl Easycast B1A Mini Thermo scientific 
Eppendorf tubes   Sarstedt 
Freezer (- 20 °C)   Electrolux 
Freezer (- 80 °C) C66085 New Brunswick Scientific 
GelDoc 2000   Bio-Rad 
Heat incubators (30 °C, 37 °C)   ASSAB 
Microcentrifuge 5415 R Eppendorf AG 
PCR machine   VWR 
Petri plates   Gosselin 
pH-meter PHM92 Unigen 
Pipette tips 10 µl Molecular BioProducts 
Pipette tips 200 µl, 1 ml Sarstedt 
Pipettes   Eppendorf 
Pyrex baffled Erlenmeyer flask 250 ml Sigma-Aldrich 
QIAEX II Suspension Lot no. 133214960  QIAGEN 
QIAquick Gel Extraction Kit  QIAGEN 
QIAquick PCR purification kit   QIAGEN 
QIAquick spin columns, collection tubes   QIAGEN 
Shaking incubators (30 °C, 37 °C) 28573 Infors HT multitron 
Spectrophotometer SpectraMax Plus 384 Molecular Devices 
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Equipment Specification Producer 
SpeedVac Concentrator Savant SPD 2010 Thermo Electron Corporation 
Vortex   Heidolph 
Wizard Genomic DNA Purification Kit   Promega 
Wizard Plus SV Minipreps DNA 
Purification Kit 
  Promega 
Wizard SV Minicolumns   Promega 
The bacterial strains and plasmids that were used are given in Table 2.1.3 and 2.1.4, 
respectively. Plasmid maps are given in Attachment D (page 81). 
Table 2.1.3: The characteristics of bacterial strains used. 
Bacterial strains Genotype/ phenotype Source/ 
reference 
Escherichia coli 
DH5α 
High efficiency transformation strain.  
Genotype: supE44 ΔlacU169 recA1 endA1 gyrA96 thi-1 relA1 
(Reisner et 
al., 2003) 
Escherichia coli 
DH10B 
High transformation efficiency and maintenance of large 
plasmids. Genotype: F
-
 mcrA Δ(mrr-hsdRMS-mcrBC) 
Φ80dlacZΔM15 ΔlacX74 recA1 endA1 araD139 Δ(ara, 
leu)7697 galU galK λ- rpsL (StrR) nupG 
 
(Wu et al., 
2010) 
Escherichia coli 
EC100 
TransforMax™ EC100™ Electrocompetent E. coli from 
Epicentre, Catalog No. EC10010 
Genotype: F
-
 mcrA Δ(mrr-hsdRMS-mcrBC) Φ80dlacZΔM15 
ΔlacX74 recA1 endA1 araD139 Δ(ara, leu)7697 galU galK λ- 
rpsL (Str
R
) nupG 
Epicentre 
Escherichia coli 
ET125671 
(pUZ8002)  
Methylation deficient (dam
-
, dcm
-
, hsdM
-
), contains helper 
plasmid pUZ8002 (Kan
R
, Cml
R
) which mediates conjugative 
DNA transfer from RP4 oriT. 
(MacNeil et 
al., 1992) 
Streptomyces 
venezuelae ATCC 
10712 (ISP5230) 
Wild type, GC-rich, linear chromosomes, produces 
Chloramphenicol and Jadomycin B.  
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Table 2.1.4: A list of the plasmids used in this master thesis. 
Plasmids Characteristics Source 
pUC59 
(4750 bp) 
T7.3_GUS Reporter gene (gusA), Amp
R
  Synthetic gene, UC Berkeley 
USA 
pGEM7ermLi Strong constitutive promoter for the gene ermE 
(resistence to erythromycin) 
C.R. Hutchinson, Wisconsin 
Madison USA 
pSOK805  
(6562 bp) 
Based on pKT02, with oriT from pSOK804 
Amp
R
, Thio
R
, RP4 oriT, attP, int, ColElori 
(Van Mellaert et al., 1998, 
Sekurova et al., 2004) 
Made during the project work 
pSOK807  
(6861 bp) 
pSOK805-ermE*p: Amp
R
, Thio
R
,  
RP4 oriT, attP, int, ColElori 
This work 
Construct 1 
(8803 bp) 
pSOK805-ermE*p-gusA, Amp
R
, Thio
R
, RP4 
oriT, attP, int, ColElori 
This work 
Construct 2 
(8781 bp) 
pSOK805-cmlFp-gusA, Amp
R
, Thio
R
, RP4 oriT, 
attP, int, ColElori 
This work 
Construct 3 
(8738 bp) 
pSOK805_kefBp-gusA, Amp
R
, Thio
R
, RP4 oriT, 
attP, int, ColElori 
This work 
Construct 4 
(8401 bp) 
pSOK805-gusA, Amp
R
, Thio
R
, RP4 oriT, attP, 
int, ColElori 
This work 
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2.2 PROCEDURES  
The aim of this Master thesis is to make biosensor plasmids by placing a reporter gene 
under the transcriptional control of promoters upstream of transporter genes in the Cml 
gene cluster. A list of the procedure and specific methods used is given below. All the 
methods are described in detail in Chapter 2.3 and the recipes for making media, 
buffers and stock solutions are given in Attachment A and B (at page 74 and 76). 
2.2.1  Construction and verification of the biosensor vectors 
Four vectors with the following characteristics were constructed, and their plasmid 
maps are presented in Figure 2.2.1 and in Attachment D (page 81). These vectors will 
hereby be referred to as construct 1, 2, 3 and 4, respectively. 
1. Positive control: pSOK805– ermE* (constitutive) promoter– gusA reporter gene 
2. Biosensor: pSOK805 – cmlF promoter – gusA reporter gene 
3. Biosensor: pSOK805 – kefB promoter – gusA reporter gene 
4. Negative control: pSOK805 – gusA reporter gene 
 
Figure 2.2.1: Biosensor and control constructs for reporter assay analysis. The upper and lower 
left constructs are for positive and negative control, containing a strong promoter and no 
promoter, respectively. The plasmids to the right are biosensor constructs which contain 
promoters controlling transporter genes in the Cml gene cluster. All the constructs contain 
origin of replication (ColElori) and Ampicillin resistance gene (bla) for replication and selection 
in E. coli strains. They also contain origin of transfer (RP4 oriT) as well as an integrase gene (int) 
and attachment site (attP) which provides site-specific integration of the plasmid DNA into the 
genome of S. venezuelae. The tsr gene confers resistance to thiostrepton for selection of S. 
venezuelae transconjugants, and the gusA reporter gene encodes a β-Glucuronidase enzyme. 
Construct 1: 
Positive 
control 
Construct 2: 
Biosensor 
Construct 4: 
Negative 
control 
Construct 3: 
Biosensor 
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Due to some problems with assembling construct 1 in a one-step reaction, a new 
strategy was proposed to ensure the construction of this plasmid. The three fragments 
should be assembled together in two steps. First vector and promoter were assembled 
to result in pSOK807 (pSOK805-ermE*p). This new plasmid was PCR-amplified to 
ensure overlapping terminal sequences with the reporter gene, and the fragments were 
combined by the ‘Gibson’ reaction. The general procedure for construction and 
verification of the biosensor constructs is described below. 
1. Amplification of DNA fragments by PCR:  
Templates for PCR-amplification of the cmlF and kefB promoters were made 
by isolation of genomic DNA from S. venezuelae (wild type), as described in 
Chapter 2.3.3. The PCR-mixes were made as described in section 2.3.4 and the 
PCR-programs are given in Table 2.3.5 and 2.3.6. Primer specifications are 
given in Attachment C (page 80). A small amount (3 µl) of each PCR-product 
was analyzed by DNA gel electrophoresis, described in section 2.3.5, to check 
for byproducts.  
2. Isolation and purification of DNA fragments from PCR: 
The PCR-product with vector and reporter gene fragments also contained 
several byproducts, as indicated by several bands on the agarose gel after DNA 
gel electrophoresis. These fragments were therefore isolated from the agarose 
gel as described in Chapter 2.3.6. The promoter fragments were pure enough to 
be isolated directly from the PCR mixes, as described in Chapter 2.3.7. 
3. DpnI-treatment of the purified vector and reporter fragments: 
The PCR-amplified pSOK805 vector and the gusA reporter fragments were 
digested with DpnI in order to digest the original, methylated DNA templates. 
This is important to ensure that the PCR-templates were removed, because they 
contained an ampicillin resistance gene. The procedure for DpnI-treatment is 
described in section 2.3.12.  
4. ‘Gibson’ assembly and transformation of E. coli: 
‘Gibson’ ligation of the fragments is described in Chapter 2.3.11 (and 1.9.1). 
After the isothermal reaction, the ligation mixes were transformed into E. coli 
cells (DH5α, DH10B or EC100), as described in Chapter 2.3.9. The 
transformation mixes were plated on LA with ampicillin (Amp), and placed for 
overnight incubation at 37 °C. The chemically competent and electrocompetent 
E. coli DH10B cells were prepared as described in Chapter 2.3.8. 
5. Isolation and verification of constructs: 
Ampicillin-resistant clones were selected and inoculated overnight as described 
in Chapter 2.3.1. Plasmid DNA (pDNA) was isolated from the overnight 
cultures as described in Chapter 2.3.10, and then digested with one or several 
restriction enzymes as described in Chapter 2.3.12. In order to verify the 
plasmids, the digestion mixes were analyzed by gel electrophoresis as described 
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in Chapter 2.3.5. The resulting fragments were compared to the ladder band 
sizes (given in Attachment E, page 83) and to the expected fragment sizes 
which are given in Table 2.3.12 - 2.3.14 in Chapter 2.3.12. 
2.2.2  Conjugative DNA transfer from E. coli ET12567 into S. venezuelae 
1. Cloning the constructs into E. coli ET12567 cells: 
Preparation of chemically competent E. coli ET12567 (pUZ8002) cells was 
performed as described in section 2.3.8. The constructs were first introduced into 
ET12567 cells as described in Chapter 2.3.9. The transformation mixes were plated 
on LA with Amp, Cml and kanamycin (Kan) to select for the two plasmids 
(original pUZ8002 and construct 1, 2, 3 or 4) and placed at 37 °C for overnight 
incubation. Three resistant clones were selected and plated on LA with Amp, Cml 
and Kan. The next day, one well-grown ET12567 clone was chosen for 
conjugation. Overnight cultures were also prepared from these three colonies in 
order to make glycerol stocks as described in Chapter 2.3.2. 
2. Conjugative DNA transfer: 
An ISP4 plate with S. venezuelae wild type (wt) was prepared 1-2 days ahead of 
the planned conjugation, in order to prepare a fresh spore suspension for this 
procedure. A glycerol stock of S. venezuelae wt could also be used for conjugation, 
but it needs more time to grow prior to selection with antibiotics. The conjugative 
DNA transfer from E. coli ET12567 into S. venezuelae is described in Chapter 
2.3.13. The transconjugants were picked and transferred to ISP4 medium 
supplemented with nalidixic acid (Nal) to select against E. coli cells and 
thiostrepton (Thio) to select for S. venezuelae with the construct inserted into its 
genome. Glycerol stocks of the transconjugants were made as described in Chapter 
2.3.2, in order to store the strains at – 80 °C. 
2.2.3  Analysis of chloramphenicol production in cultured S. venezuelae 
Overnight cultures of S. venezuelae transconjugants with the inserted constructs were 
made by inoculating a strain (either from the glycerol stock or from a fresh spore 
suspension) in TSB medium (10 ml). The conjugative transfer of construct 1 (positive 
control) into S. venezuelae did not result in any real transconjugants that could grow 
on ISP4 medium supplemented with Thio. Time was running out, so some spores were 
picked up from an ISP4 plate with Nal and Thio, and inoculated in TSB (10 ml) 
supplemented with Thio (30 µg/ml). The strain with construct 1 did not grow at 30 °C 
overnight, so it was not cultured as the other strains. The overnight cultures of S. 
venezuelae with introduced construct 2, 3 and 4 were inoculated in MYM medium     
(2 × 50 ml) and grown in baffled flasks at 30 °C for 10 hours, before ethanol (6 %, 
v/v) was added to half of the cultures. Twelve hours after addition of ethanol, 6 × 1 ml 
samples were collected from each flask. Three of them were prepared for Ultra high 
Performance Liquid Chromatography (UPLC) analysis as explained in Chapter 2.3.14, 
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and the other 3 parallels were used for reporter assay analysis. Four days after 
inoculation into MYM medium, the same amount of samples were collected once 
more and prepared for the two analysis methods. 
2.2.4  Reporter assay 
While culturing the different transconjugants to analyze the Cml production, samples 
were also collected for the reporter assay analysis and stored at -20 °C. This was 
performed in order to give comparable results. The protocol for analysis of reporter 
gene expression is described in Chapter 2.3.15.  
29 
 
2.3 PROTOCOLS 
The laboratory protocols are described in the following subchapters. Recipes for the 
media, buffers and stock solutions used are listed in Attachment A and B (page 74 and 
76), respectively. 
2.3.1  Overnight cultures 
Overnight cultures are used to increase the cell concentration in order to isolate 
genomic DNA, pDNA or make a glycerol stock. The following procedure describes 
how to make overnight cultures of S. venezuelae and different E. coli strains.  
Materials: 
 Bacterial strain from freezer, colony from an agar plate or previous overnight 
culture 
 Growth medium: LB for E. coli, TSB for S. venezuelae ATCC 10712 
 Antibiotics for selection: Ampicillin (Amp), Chloramphenicol (Cml), 
Kanamycin (Kan) 
 Sterile toothpicks or loops 
Overnight cultures can be made by inoculating a strain from the freezer, a colony from 
an agar plate, or from a previous overnight culture. E. coli was inoculated in LB 
medium (2 ml), with a certain antibiotic for plasmid selection, and incubated overnight 
in a 37 °C shaker (225 rpm). In order to cultivate E. coli strains transformed with 
‘Gibson’ ligation mixes, LB medium (2 ml) was added Amp (100 mg/ml, 2 µl) to 
select for cells containing pDNA with an Amp
R
 gene. E. coli ET12567 contains a 
helper plasmid which has to be selected for by adding Cml (30 mg/ml, 2 µl) and Kan 
(40 mg/ml, 1 µl) to 2 ml of LB medium, in addition to Amp (100 mg/ml, 2 µl).  
S. venezuelae was inoculated in TSB medium (2 ml) and incubated overnight in a 
30°C shaker (225 rpm).  
2.3.2  Glycerol stocks 
Bacterial strains can survive for several years if they are stored at -80 °C in a glycerol 
solution. The following procedure describes how to make glycerol stocks of E. coli 
and S. venezuelae strains. 
Materials: 
 Overnight culture (E. coli) or fresh spores from an ISP4 plate (S. venezuelae) 
 Sterile 20 % Glycerol solution 
 Sterile cryo vials 
 Sterile cotton wool filters (S. venezuelae) 
 Centrifuge 
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Protocol for E. coli glycerol stocks: 
1. The overnight culture (1.5 ml) was transferred to an Eppendorf tube under 
sterile conditions. 
2. The tube was centrifuged (13 000 rpm, 4 min), followed by removing the 
supernant. 
3. The cells were resuspended in 20 % Glycerol (1.5 ml) and the cell suspension 
was transferred to a cryo vial for storage at -80 °C. 
Protocol for S. venezuelae glycerol stocks: 
1. A glycerol solution (20 %, 4 ml) was applied onto an ISP4 plate with fresh S. 
venezuelae spores and the plate was rubbed with light movements to detach the 
spores from the plate. 
2. The spore suspension was filtered through a sterile cotton wool filter and the 
filtrate was transferred to a cryo vial for storage at -80 °C. 
2.3.3  Isolation of genomic DNA 
Isolation of genomic DNA from Streptomyces venezuelae ATCC 10712 was 
performed by using the Wizard® Genomic DNA Purification Kit from Promega. The 
protocol for Gram positive Bacteria was followed as described in Attachment F1. 
Materials: 
 Wizard Genomic DNA Purification Kit 
 Overnight cell culture of Streptomyces venezuelae ATCC 10712 
 Sterile Eppendorf tubes (1.5 ml) 
 Isopropanol 
 Ethanol (70 %) 
 Lysozyme (10 % in 50 mM EDTA) 
 Water bath at; 37 °C, 65 °C and 80 °C. 
 Centrifuge 
 
2.3.4  Polymerase chain reaction (PCR) 
Polymerase chain reaction (PCR) is used for in vitro amplification of certain DNA 
fragments. The reaction is based on temperature cycles where DNA is denatured, 
annealed to primers and then elongated by DNA polymerase (Madigan et al., 2009). 
Different polymerase mixes were used to amplify fragments of varying lengths. Most 
fragments were amplified with Expand High Fidelity DNA polymerase. This enzyme 
mix contains thermostable Taq DNA polymerase and thermostable Tgo DNA 
polymerase which has proofreading activity (Roche, 2011). Long vector fragments   
(6-8 kb) were sometimes problematic to amplify. In those cases, MasterAmp Extra-
Long DNA Polymerase Mix was used to increase the amount of PCR product. This 
polymerase mix also contains thermostable Taq DNA polymerase and unspecified 
proofreading polymerase(s). 
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Materials: 
 Template: plasmid DNA, genomic DNA etc. which contains the desired 
sequence 
 Primers (10 µM): forward and reverse (given in Attachment C) 
 Thermostable DNA polymerases  
 Deoxyribonucleotides (dNTP’s, 10mM): 4 types  
 Buffers: GC-rich for amplification of Streptomyces genes, High Fidelity 2× 
Long PCR premixes for long fragments 
 PCR machine 
Reaction mixes:  
The PCR-mixes in Table 2.3.1 were used for amplification of (pSOK805) vector 
fragments for the biosensor constructs. These long vector fragments were amplified 
with the PCR-program “Ingrid2”, which is described in Table 2.3.5.  
Table 2.3.1: PCR-mixes for amplification of vector fragments with PCR-program “Ingrid2”. 
  Construct 1: Construct 2: Construct 3: Construct 4: 
Vector fragments:  pSOK805  pSOK805  pSOK805  pSOK805 
Ingredients amount [µl] amount [µl] amount [µl] amount [µl] 
Template (pSOK805) 1 1 1 1 
Primers (see Attachment C) 1+1 1+1 1+1 1+1 
ds H2O 8 7.5 8 8 
DMSO 0.5 0.5 0.5 0.5 
MgCl2  
 
0.5   
High Fidelity 2x Long PCR premix: nr. 5: 12.5 nr. 9 : 12.5 nr. 9: 12.5 nr. 9: 12.5 
EHF Polymerase 1   1 1 
MasterAmp Extra-Long Pol. Mix 
 
1   
Total volume 25 25 25 25 
The different promoters for construct 1, 2 and 3 were amplified by using the PCR-
mixes given in Table 2.3.2. The PCR-programs “Ingrid1” and “SZ3” were used as 
indicated in the table and these programs are described in Table 2.3.5 and 2.3.6, 
respectively. The pGEM7ermLi plasmid was used as template for the strong 
constitutive promoter (ermE*p). The genomic DNA of Streptomyces venezuelae was 
isolated as described in section 2.3.3, and used as template for the promoters in 
construct 2 and 3 (cmlFp and kefBp). Construct 4 has no promoter since it is the 
negative control plasmid and should not express the reporter gene under any 
conditions. 
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Table 2.3.2: PCR-mixes for amplification of the promoters for construct 1, 2 and 3. 
  Construct 1: Construct 2: Construct 3:  
Promoter fragments: ermEp cmlFp kefBp 
Ingredients amount [µl] amount [µl] amount [µl] 
Template (pGEM7ermLi (c.1),  
S. venezuelae genomic DNA (c.2, 3)) 
1 1 1 
Primers (see Attachment C) 1+1 1+1 1+1 
ds H2O 8 6.5 6.5 
DMSO 0.5 0.5 0.5 
High Fidelity 2x Long PCR premix nr. 7 12.5    
dNTP’s (10 mM)   1 1 
GC-rich buffer (10x) with MgCl2   4 4 
GC-rich resolution solution   4 4 
EHF Polymerase 1 1 1 
Total volume 25 20 20 
PCR-program “Ingrid1” “SZ3” “SZ3” 
Amplification of the reporter genes was performed with the PCR-mixes given in Table 
2.3.3. The plasmid template (pUC59) was diluted 5 times prior to the PCR-mix for 
construct 2, due to a high plasmid concentration. A plasmid map of this template is 
presented in Attachment D (page 81). The PCR-programs “Ingrid1” and “Ingrid4” 
were used to amplify the gusA gene fragments, and these programs are described in 
Table 2.3.5 and 2.3.6, respectively. 
Table 2.3.3: PCR-mixes for amplification of the gusA reporter gene fragments. Different PCR-
programs were used as indicated in the last row. 
  Construct 1: Construct 2: Construct 3: Construct 4: 
Reporter fragments:  GusA_erm  GusA_cml  GusA_kef  GusA_noPro 
Ingredients amount [µl] amount [µl] amount [µl] amount [µl] 
Template (pUC59) 1 1 (5 x diluted) 0.5 0.5 
Primers (see Attachment C) 1+1 1+1 1+1 1+1 
ds H2O 8 8 8.5 9 
DMSO 0.5 0.5 0.5   
HF 2x Long PCR premix  nr. 8: 12.5 nr. 8: 12.5  nr. 5, 7: 12.5 nr. 8: 12.5 
EHF Polymerase 1 1 1 1 
Total volume 25 25 25 25 
PCR-program: “Ingrid4” “Ingrid4” “Ingrid1” “Ingrid4” 
Construct 1 (the positive control plasmid)  was assembled in two steps. First, the PCR-
amplified pSOK805 vector fragment was assembled with the ermE* promoter by the 
‘Gibson’ reaction, resulting in a new vector called pSOK807. Then, this new vector 
was PCR-amplified to enable introduction of the gusA gene fragment downstream of 
the promoter, resulting in the right construct 1. The PCR-mix for amplification of the 
assembled pSOK807 plasmid is given in Table 2.3.4. 
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Table 2.3.4: The PCR-mix for amplification of pSOK807 vector to ensure the final assembly of 
construct 1 in two steps.  
  Construct 1: 
Vector fragments:  pSOK807 
Ingredients amount [µl] 
Template: pSOK807 colony 11 1 
Primers: pSOK807-F and -R 1+1 
ds H2O 8 
DMSO 0.5 
High Fidelity 2x Long PCR premix nr. 7 12.5 
MasterAmp Ex.-Long DNA Pol. Mix 1 
Total volume 25 
PCR-program: “Ingrid2” 
These PCR-amplified DNA fragments were analyzed by DNA gel electrophoresis and 
assembled with the ‘Gibson’ reaction as described in Chapter 2.3.11. 
PCR-programs used: 
The PCR-programs that were used to amplify different DNA fragments are specified 
in Table 2.3.5 and 2.3.6. 
Table 2.3.5: The PCR-programs used for amplification of several DNA fragments. “Ingrid1” 
was used for amplification of small DNA fragments, while “Ingrid2” was used for longer vector 
fragments as pSOK805. 
    Ingrid1   Ingrid2   
Step Process Temperature [°C] 
Time 
[min] Temperature [°C] 
Time 
[min] 
1 Denaturation 94 2 94 1 
2 Continued denaturation 94 0.75 95 0.5 
3 Annealing 58 1 56 1 
4 Elongation 68 4 68 7 
5 Continued elongation 72 6 68 8 
6 Cool down 4 ∞ 4 ∞ 
Repeated cycles (step 2-5)  35   30 
 
Table 2.3.6: PCR-programs used for amplification of DNA fragments. “SZ3” was used for 
amplification of the promoters for construct 1, 2 and 3, while “Ingrid4” was used for 
amplification of some gusA reporter genes. 
    SZ3   Ingrid4   
Step Process Temperature [°C] 
Time 
[min] Temperature [°C] 
Time 
[min] 
1 Denaturation 95 5 95   1 
2 Continued denaturation 95 1 95  0.75 
3 Annealing 60 1 70  5 
4 Elongation 72 4 70  5 
5 Continued elongation 72 7 72 10 
6 Cool down 4 ∞ 4   ∞ 
Repeated cycles (step 2-5)  35   25   
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2.3.5  DNA gel electrophoresis 
Gel electrophoresis is a widely used technique to separate differently sized biological 
macromolecules, such as nucleic acids and proteins. DNA is negatively charged due to 
the phosphate groups, and will therefore migrate from the negative to the positive pole 
in an electric field (Madigan et al., 2009). Small fragments will migrate faster through 
the agarose gel than larger fragments because differently sized pores in the gel restrict 
migration of larger molecules the most (Klug et al., 2009). Hence, the DNA mix will 
be separated according to fragment sizes. During this work, gel electrophoresis was 
performed to check if the correct PCR product was amplified, and to check the purity 
and amount of isolated DNA. 
Materials: 
 0.8 % Agarose gel 
 1 × TAE-buffer 
 Gel electrophoresis equipment 
 Gel Doc 2000 
 Loading dye 
 DNA ladder 
Protocol: 
Agarose solution was prepared as described in Attachment B3 (page 76). The gel was 
made by filling liquid 0.8 % agarose solution in a gel-form with an appropriate sized 
well-maker. After the gel had cooled down and stiffened, the gel was covered with 
1×TAE-buffer. A DNA ladder (2 - 3 µl) was filled in the first well. DNA samples with 
loading dye were added to the following wells. To check a PCR-product, 3 µl of the 
PCR product was mixed with dsH2O (7 µl) and loading dye (10x, 1 µl), before loading 
the suspension into a well in the gel. In order to isolate DNA from the agarose gel or 
analyze digested pDNA, the whole amount of sample was loaded in one well. The gel 
was run at 80-110 V for 40-90 minutes until sufficient separation of fragments was 
achieved. DNA bands were visualized with UV-light in Gel Doc 2000. By comparing 
the DNA bands with the ladder, the approximate size of the fragment can be estimated. 
The band sizes of the ladder used is given in Attachment E (page 83). 
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2.3.6  Isolation of DNA fragments from agarose gel 
The DNA band of expected size was cut from the gel and purified with QIAquick Gel 
Extraction Kit or QIAEX II suspension from QIAGEN. The QIAEX II suspension was 
used for smaller amounts of PCR products. The two protocols are described in 
Attachment F2 (page 85). 
Materials: 
 QIAquick Gel Extraction Kit 
 QIAGEN spin columns and collection tubes 
 Isopropanol 
 QIAEX II suspension 
 Centrifuge 
 
2.3.7  Purification of PCR product 
When the PCR product was pure (indicated by only one DNA band after gel 
electrophoresis), the DNA could be purified directly from the PCR tube. For this 
purpose, QIAquick PCR Purification Kit from QIAGEN was used and the protocol is 
described in Attachment F3 (page 86). 
Materials: 
 QIAquick PCR Purification Kit 
 QIAGEN spin columns and collection tubes 
 Centrifuge 
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2.3.8  Preparation of competent E. coli cells 
Competent cells are highly capable of accepting plasmids. E. coli DH10B was used for 
intracellular plasmid replication and E. coli ET12567 was used for conjugative DNA 
transfer into S. venezuelae.  
Preparation of chemically competent E. coli DH10B and E. coli ET12567: 
Materials: 
 Glycerol stock of E. coli cells from the -80 °C freezer: DH10B or ET12567 
 LB medium 
 Plasmid DNA 
 TSS-buffer 
 Ice 
 Cold centrifuge 
Protocol: 
1. E. coli DH10B or ET12567 cells from a glycerol stock were inoculated in LB 
medium (2 ml). The ET12567 cells were incubated with Cml (30 mg/ml, 2 µl) 
and Kan (40 mg/ml, 1 µl) to select for the helper plasmid. The cultures were 
incubated in a shaker overnight (37 °C, 225 rpm). 
2. Some of the overnight culture (0.4 ml) was inoculated in 40 ml LB medium 
(added Cml (40 µl) and Kan (20 µl) for preparation of E. coli ET12567 
competent cells) and incubated for approximately 2 h in a shaking incubator  
(37 °C, 225 rpm) until OD600 was between 0.4– 0.6. 
3. The cell suspension was centrifuged (4500 rpm, 5 minutes, 4 °C), and the 
supernatant was removed. The cells were resuspended in 4 ml cold TSS- buffer. 
4. The cell suspension was kept on ice for 1 hour, then distributed into several 
Eppendorf tubes and used for transformation or stored at -80 °C. 
 
Preparation of electrocompetent E. coli DH10B: 
Materials: 
 dsH2O 
 10 % v/v glycerol solution 
 LB medium 
 Overnight culture of desired cells 
 50 ml cubic tubes 
 Cold centrifuge 
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Protocol: 
1. An overnight culture (3 ml) was inoculated in LB medium (300 ml). The 
culture was grown in a 37 °C shaker until the OD600 = 0.35 -0.4.  
2. The cells were put on ice and chilled for 20-30 minutes and then distributed into 
6 cold 50 ml cubic tubes. 
3. The bottles were centrifuged at 2400 rpm for 20 min at 4 °C. 
4. Supernatant was decanted and each pellet was resuspended in 40 ml of ice cold 
dsH2O. 
5. Step 3 and 4 was repeated and the pellet was resuspended in 20 ml of ice cold 
dsH2O, before centrifuging under the same conditions. 
6. The supernatant was decanted and each pellet was resuspended in 8 ml of ice 
cold 10 % glycerol solution. Suspensions were combined, resulting in 2 bottles 
with 24 ml in each. 
7. The bottles were centrifuged again under the same conditions. 
8. The supernatant was carefully aspirated with a pipette and the remaining cells 
were resuspended in 200 ml of ice cold 10 % glycerol solution by swirling the 
tube gently. 
9. The competent cells were distributed into eppendorf tubes, 100 µl in each, and 
stored at -80 °C. 
 
2.3.9  Transformation 
Transformation is a process where extracellular DNA is introduced into a (competent) 
host cell. The extracellular DNA is a plasmid/vector containing a gene that confers 
antibiotic resistance to the transformed cells. This makes it possible to select for 
transformed cells by growing them on media with antibiotic(s), where only the 
plasmid-containing cells can grow. The following procedure for transformation was 
used for chemically competent E. coli strains: DH10B and ET12567. Electroporation 
with electrocompetent E. coli DH10B and EC100 cells is also described below. This 
procedure introduces vectors into the cells by applying a small voltage on the cell 
suspension, which makes the cells permeable to DNA (Chassy et al., 1988). 
Electroporation is generally more efficient than heat shock transformation. 
Materials: 
 Competent cells: 100 µl in Eppendorf tubes  
 Plasmid(s) 
 Ice 
 Water bath at 42 °C or electroporator and cuvettes 
 LB medium 
 Shaking incubator (37 °C) 
 Agar plates with antibiotic(s) for selection 
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Heat shock transformation: 
1. The frozen competent cells were melted slowly on ice. 
2. Plasmid DNA or ‘Gibson’ ligation mix (1-3 µl per 100 µl competent cells) was 
added and the cells were kept it on ice for approximately 15 minutes. 
3. Heat shock was performed at 42 °C for 45 seconds to destabilize the cell wall 
so that plasmids could enter the cells. 
4. The cells were placed on ice for 2-10 minutes. 
5. LB media (400 µl) was added to each tube and the cells were incubated for 1-2 
hours in a shaking incubator (37 °C, 225 rpm). 
6. 100 µl of the transformation mixes were plated on each agar plate with 
appropriate antibiotic(s) for plasmid selection. The plates were incubated 
overnight at 37 °C. 
Electroporation: 
1. Plasmid DNA or ‘Gibson’ ligation mix (2 µl) was added to electrocompetent 
cells (100 µl) in an eppendorf tube and mixed carefully without pipetting. The 
cells were kept on ice for 10-30 min. 
2. The cells were transferred to a cold cuvette and placed on ice. 
3. Ice and water was wiped off the cuvette before it was placed into the 
electroporator device. Electroporation was performed by running the protocol 
(voltage: 2500 V, capacitance: 25 C, resistance: 100 Ω, cuvette: 1mm). 
4. After the electroporation, 500 µl of LB medium was added to the cuvette. The 
content was mixed by pipetting and transferred to an eppendorf tube, which was 
incubated for 1-2 hours (37°C, 225 rpm). 
5. 100 µl of the transformation mixes were plated on each agar plate with 
appropriate antibiotic(s) for plasmid selection. The plates were incubated 
overnight at 37 °C. 
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2.3.10 Isolation of plasmid DNA (pDNA) 
Plasmid DNA was isolated from overnight cultures of transformed cells by using 
Wizard® Plus SV Minipreps DNA Purification System from Promega. The protocol is 
described in Attachment F4 (page 87). 
Materials: 
 Wizard® Plus SV Minipreps DNA Purification Kit 
 Wizard® SV Minicolumns 
 Overnight culture of transformed cells 
 
2.3.11 ‘Gibson’ reaction 
As described in Chapter 1.9.1, the ‘Gibson’ one-step isothermal reaction was used to 
join DNA fragments for construction of new vectors. By specific designed primers, 
overlapping terminal sequences of 25 bp were added to the DNA fragments and 
amplified by PCR. Vector and reporter fragments were treated with DpnI (described in 
Chapter 2.3.12) to digest methylated PCR template. The plasmids pSOK805 and 
pUC59, which were templates for the vector and gusA reporter gene, both contained an 
ampicillin resistance gene. It was therefore important to remove all traces of the 
plasmids before the ‘Gibson’ reaction was performed. 
The DNA fragments were added in equimolar amounts to 15 µl of the ‘Gibson’ master 
mix, described in Attachment B7, until a total volume of 20 µl. The reaction mixes 
(Table 2.3.8 and 2.3.9) were incubated at 50 °C for 1 hour in the PCR-machine by 
using program “ingib” described in Table 2.3.7.  
Table 2.3.7: PCR-program details for the ‘Gibson’ reaction. 
    ingib   
Step Process Temperature [°C] Time [min] 
1 ‘Gibson’ ligation 50 60 
2 Cool down 4 ∞ 
Composition of the ‘Gibson’ reaction mixes for assembling the construct 2, 3 and 4 in 
one step is described in Table 2.3.8. Negative control reactions were made by adding 
the same amount of fragments, but with distilled sterile water (ds H2O) instead of the 
promoter. ‘Gibson’ assembly should not be possible without the promoter fragments. 
The negative control mixes were transformed into E. coli, in order to detect possible 
background “noise” created by transformation of un-digested templates. 
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Table 2.3.8: ‘Gibson’ reaction mixes for assembling construct 2, 3 and 4 in one step. Reaction 
mixes without the promoter was performed as a negative control. 
Construct nr. 2 
Control for 
construct 2 3 
Control for 
construct 3 4 
Control for 
construct 4 
Vector [µl] 1 1 1 1 0,5 0,5 
Promoter [µl] 2 2 µl ds H2O 1,5 1,5 µl ds H2O - - 
Reporter [µl] 2 2 2,5 2,5 4,5 4,5 µl ds H2O 
Gibson master mix [µl] 15 15 15 15 15 15 
Total volume [µl] 20 20 20 20 20 20 
Construct 1 was assembled in two steps. The composition of the two ‘Gibson’ reaction 
mixes is described in Table 2.3.9. 
Table 2.3.9: The ‘Gibson’ reaction mixes for assembling construct 1 in two steps. 
Construct: pSOK807 
Control for 
pSOK807 Construct nr. 1 
Control for 
construct 1 
Vector [µl] 3 3 Vector [µl] 2 2 
Promoter [µl] 2 2 µl ds H2O Reporter [µl] 3 3 µl ds H2O 
Gibson master mix [µl] 15 15 Gibson master mix [µl] 15 15 
Total volume [µl] 20 20 Total volume [µl] 20 20 
 
2.3.12 Enzyme digestion 
DpnI-treatment: 
The PCR-amplified vector and reporter fragments were treated with DpnI in order to 
digest original, methylated pDNA, and make sure that only the PCR product was 
present before the ligation reaction. DNA from common E. coli strains is Dam-
methylated and therefore susceptible to DpnI digestion (Weiner et al., 1994). The 
DpnI-treatment was performed by incubating the following mixture in the PCR 
machine, using the PCR-program “osdpnI” or “DpnLong” as described in Table 
2.3.10. 
 17 µl purified vector 
 1 µl DpnI 
 2 µl NEB buffer 4  
Table 2.3.10: PCR-program for DpnI-treatment of vector and reporter fragments. 
    osdpnI   DpnLong   
Step Process 
Temperature 
[°C] Time [min] 
Temperature 
[°C] Time [min] 
1 Enzyme digestion 37 120 37 480 
2 Enzyme inactivation 80 20 80 20 
3 Cool down 4 ∞ 4 ∞ 
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Enzyme-digestion of the constructs: 
In order to verify the constructs, pDNA was first isolated from overnight cultures of 
transformants, as described in Chapter 2.3.10. The pDNA was then digested with 
restriction enzymes, and analyzed by gel electrophoresis. The pDNAs were cut by 
incubating the digestion mixes, described in Table 2.3.11, in a water bath at 37 °C for 
1 hour.  
Table 2.3.11: Enzyme mixes for digestion of pDNA. 
  PstI-digestion Eco0109-digestion AatII-digestion XmaI-digestion 
  Amount [µl] Amount [µl] Amount [µl] Amount [µl] 
ds H2O 13.5 13.5 14 13.5 
NEB buffer nr. 3: 2 µl nr. 4: 2 µl nr. 4: 2 µl nr. 4: 2 µl 
BSA 0.5 0.5 - 0.5 
pDNA 3 3 3 3 
Enzyme 1 1 1 1 
The expected band sizes after proper enzyme digestion of the constructs are given in 
Table 2.3.12-2.3.14. 
Table 2.3.12: Expected fragment sizes after PstI-digestion of the constructs and pSOK805. 
Construct  1 (ermEp) 2 (cmlFp) 3 (kefBp) 4 (noPro) pSOK807 pSOK805 
Restriction enzyme PstI PstI PstI PstI PstI PstI 
Band sizes [bp] 6698 6654 6654 6654 4882 5967 
  1384 1532 1489 1152 1384 595 
  595 595 595 595 595   
  126           
Table 2.3.13: Expected fragment sizes after XmaI-digestion of construct 2, 3, 4 and pSOK805. 
Construct  2 (cmlFp) 3 (kefBp) 4 (noPro) pSOK805 
Restriction enzyme XmaI XmaI XmaI XmaI 
Band sizes [bp] 3387 3387 3387 3387 
  2835 2835 2835 3067 
  1049 1049 1049 108 
  877 834 525   
  525 525 497   
  108 108 108   
Table 2.3.14: Expected fragment sizes after AatII- digestion of construct 2, pUC59 and 
pSOK805, and EcoO109I-digestion of construct 3 and pSOK805. 
Construct  2 (cmlFp) pUC59 pSOK805 3 (kefBp) pSOK805 
Restriction enzyme AatII AatII AatII EcoO109I EcoO109I 
Band sizes [bp] 3548 2782 5533 5991 3815 
  2688 1032 786 2278 2278 
  1032 936 243 469 469 
  786        
  484        
  243        
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2.3.13 Conjugative DNA transfer from E. coli ET 12567 to S. venezuelae 
Conjugation is a simple and efficient method for transferring pDNA from E. coli 
ET12567 into the genome of S. venezuelae ATCC 10712. The E. coli ET12567 
(pUZ8002) strain– later just ET – is a non-methylating host (dam-, dcm-) carrying 
pUZ8002 helper plasmid which provides transfer functions from RP4. The strain is 
resistant to both Cml (30 g/ml) and Kan (40 g/ml). This strain allows mobilization 
of any plasmid carrying RP4 oriT into the recipient. For laboratory conjugation, both 
fresh S. venezuelae spores as well as frozen glycerol stock of spores can be used.  
Materials: 
 E. coli ET12567 (pUZ8002) cells with introduced constructs on a fresh LA 
plate with Amp, Cml and Kan 
 ISP4 plate with S. venezuelae ATCC 10712 spores 
 Glycerol stock of  S. venezuelae ATCC 10712 spores 
 ISP4 + MgCl2 plates 
 LB medium 
 2YT medium 
 Sterile cotton wool filters 
Protocol: 
1. Prepared spore suspension of S. venezuelae in distilled sterile water by washing 
off spores from a fresh ISP4 plate with 5.0 ml of water and filtering it through 
the sterile cotton wool. Added 50 l of this spore suspension or frozen spore 
suspension to 2YT medium (500 l), mixed and incubated for 5 min at 50C 
(germination of spores are induces by this heat shock). Allowed the heat-
shocked spore suspension to cool down at room temperature (ca. 15-20 min). 
2. Prepared ET cell suspension by sampling cells from a plate and resuspending 
them in 2×YT medium (500 l). 
3. Mixed heat-shocked spore suspension of S. venezuelae (550 l) with 100 l of 
the ET cell suspension by pipetting. The mix was spun down at a table 
centrifuge for 1 min, and 550 l of the supernatant was removed. The cells were 
resuspended in the rest of the medium (100 l) and plated on ISP4 + MgCl2 
medium. The cells were grown at room temperature on the laboratory bench for 
14-23 h until a thin mycelium layer was observed (less time for fresh spores 
than for glycerol stock). 
4. Made antibiotic solution for selection of transconjugants by mixing nalidixic 
acid  (0.9 mg/ml) and thiostrepton (0.9 mg/ml) with sterile distilled water. Each 
ISP4 + MgCl2 plate with conjugation mix was added 1 ml of the antibiotic mix 
(Nal + Thio), which was evenly distributed over the surface of the plate using a 
sterile glass triangle. The resulting concentration of each antibiotic was 30 
µg/ml medium. The closed plate was left on the bench for 1 h to dry out, before 
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it was placed at 30C for further growth. Nalidixic acid (Nal) was used to select 
against contaminating E. coli, since Streptomycetes are naturally resistant to 
Nal, while E. coli is sensitive to it. Thiostrepton (Thio) was used to select for 
transconjugants, since the plasmid contained the tsr gene, which confers 
resistance to Thio. The antibiotic stock solution recipes can be found in 
Attachment B (page 76).  
5. Approximately one week after selection, some transconjugants were selected 
and transferred onto ISP4 plates with Nal (30 g/ml) and Thio (30 g/ml), and 
placed at 30 C for further growth. 
6. After 2-4 days of growth, each colony was distributed on an agar plate with 
ISP4 medium and Thio. This plate was placed at 30 C for 2-3 days until 
sporulation. Then, glycerol stocks were made from the spore suspension as 
described in Chapter 2.3.2. 
2.3.14 Analysis of chloramphenicol production in cultured S. venezuelae  
S. venezuelae recombinant strains with introduced construct 2, 3 and 4 were cultured 
for several days in order to analyze the production of chloramphenicol (Cml). Half of 
the cultures were added ethanol (6 % v/v) to stop the production of Cml. The samples 
taken from the culture broth were prepared for Ultra high Performance Liquid 
Chromatography (UPLC) analysis as described below. 
Materials: 
 S. venezuelae with introduced constructs 
 MYM medium and TSB medium 
 Ethanol (96 %) 
 250 ml baffled flasks (Pyrex) 
 Shaking incubator (30 °C) 
 Centrifuge 
 Ethyl acetate 
 SpeedVac Concentrator 
 Methanol 
Procedure for culturing the S. venezuelae strains: 
1. Spore suspension or glycerol stock (50 µl) of S. venezuelae strains were 
inoculated in TSB (10 ml) and grown overnight at 30 °C in a shaking incubator. 
2. For each strain, two baffled flasks (250 ml) were added 50 ml MYM medium. 
Overnight culture (2.5 ml) of S. venezuelae strain was added in each baffled 
flask and grown at 30 °C in a shaking incubator.  
3. After 10 hours of growth, ethanol (3.5 ml) was added to one flask of each 
strain. This resulted in a total ethanol concentration of 6 % (v/v). Addition of 
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ethanol should stop the production of Cml. The cultures were grown further 
under the same conditions. 
4. About 12 hours after addition of ethanol, six samples (1 ml) were taken from 
each culture and three of them were prepared for UPLC analysis as described 
below. The three other parallels were frozen down at -20 °C. 
5. On the fourth day of growth (72 h after the last samples were taken), the same 
amount of samples were collected once more. Three parallels were prepared for 
UPLC analysis, while the remaining three parallels were used for reporter assay 
as described in Chapter 2.3.15. 
Preparation of samples for UPLC analysis: 
1. The samples were centrifuged (13 000 rpm, 5 min) and the supernatant (0.8 ml) 
was carefully transferred to a clean tube.  
2. Ethyl acetate (0.3 ml) was added to extract Cml, and the sample was vortexed 
for 1 minute. 
3. Centrifugation (13 000 rpm, 2 minutes) resulted in a phase separation. The top 
layer consisted of ethyl acetate and Cml, while the bottom layer was the 
remaining medium. Only 0.1 ml of extract was taken from the top layer. This 
was performed fast and carefully because ethyl acetate is very volatile. 
4. Step 3 and 4 were repeated and 0.2 ml of the ethyl acetate layer was extracted 
and added to the first 0.1 ml of extract. 
5. The ethyl acetate was removed by evaporation in a SpeedVac Concentrator (5.0 
Torr, 45 °C, 40 min) and chloramphenicol was diluted in methanol (400 µl). 
6. The methanol solution (100 µl) was transferred to small brown flasks prior to 
the UPLC analysis. Only 1 µl of this solution was injected into the UPLC 
machine.  
The UPLC analysis was performed as described in (Shah et al., 2012). 
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Results from the UPLC analysis are presented as nM Cml in Attachment G. 
Calculation of the Cml concentration per ml of sample was performed by using the 
equation below, which was developed by considering the following facts: 
1. Only 0.8 ml out of the 1 ml sample was used for extraction of Cml, since the 
remainder contained pelleted cells. Thus the concentration should be multiplied 
by the factor 5/4 to get the Cml concentration in 1 ml media. 
2. Only half of the ethyl acetate added to extract Cml was collected for analysis, it 
should therefore be multiplied by 2.  
3. The ethyl acetate was evaporated and the remaining Cml powder was diluted in 
400 µl of methanol, which was analyzed by UPLC. 
4. Chloramphenicol has a molar mass of 323.14 g/mol.  
9 6 65 μg[μg/ml]= 2 c [10 mol/L]  400 10 L  323.14 g/mol  10
4 ml g
Cml CmlC
        
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2.3.15 Measurement of β-glucuronidase activity in cell lysates 
In order to investigate under which conditions the reporter gene was expressed, a 
reporter assay was performed as described below. Preparation of the buffers and 
solutions is described in Attachment B (page 76). 
Materials: 
 Samples from cultured S. venezuelae strains 
 Dilution buffer 
 Lysis buffer 
 p-nitrophenyl-β-D-glucuronide (PNPG) (0.2 M) 
 96 well plate 
 Spectrophotometer 
 Centrifuge 
 
Protocol: 
1. While collecting samples from the cultured strains for HPLC analysis, 3 × 1 ml 
was collected from each culture to use in the reporter assay. The samples were 
stored at - 20 °C and melted before use. 
2. The samples were centrifuged to pellet the cells (4 °C, 8 000 rpm, 1 minute). 
3. Supernatant was discarded, and the cells were washed in dsH2O.  
4. The cells were resuspended in lysis buffer (1 ml) and incubated at 37 °C for 15 
minutes. 
5. Samples were centrifuged  again (4 °C, 4 000 rpm, 10 min). 
6. The dilution buffer (5 ml) was mixed with PNPG substrate (50 µl, 0.2 M) and 
50 µl of this mix was distributed in a 96 well plate. 
7. Cell lysate (50 µl) was distributed into the wells which were already added 
dilution buffer and substrate. A 1:1 mixture of dilution buffer and lysate was 
used as blank references. The 96 well plate was incubated at 37 °C for 40 
minutes. 
8. The optical density (OD) was measured at light wavelengths of 405 nm and 415 
nm in a spectrophotometer.  
9. The plate was left at room temperature overnight and new OD measurements 
were performed the next morning, about 17 hours after the first measurements. 
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3  RESULTS AND DISCUSSION 
3.1 CONSTRUCTION AND VERIFICATION OF THE VECTORS 
In order to construct the biosensor plasmids, DNA fragments were PCR-amplified to 
render overlapping terminal sequences. These overlaps could then anneal during the 
‘Gibson’ assembly, resulting in a seamless vector. pSOK805 is a shuttle vector that 
can be transferred from E. coli to S. venezuelae by conjugation. DNA fragments for all 
the constructs were amplified by PCR as described in Chapter 2.3.4 with the specific 
primers given in Attachment C (page 80). Optimization of conditions for PCR 
reactions was performed for different DNA fragments. The vector and gusA reporter 
gene fragments were DpnI-treated to ensure that the PCR-template was removed, 
because the templates conferred resistance to ampicillin which was used for selection 
of transformants.  
3.1.1  Assembling construct 3: pSOK805-kefBp-gusA 
Construct 3 was the first vector to be successfully assembled by the ‘Gibson’ reaction 
and then transformed into E. coli cells. The purified DNA fragments for making 
construct 3 (pSOK805-kefBp-gusA) are shown in Figure 3.1.1. The band sizes of the 
ladder are given in Attachment E (page 83). 
 
    
Figure 3.1.1: Gel electrophoresis of the DNA fragments for making construct 3 
(pSOK805_kefBp_gusA). The content of each well is specified to the right and the ladder bands 
closest to the DNA fragments are indicated to the left. 
The DNA bands have the estimated sizes. The vector fragment in well number 2 is 
expected to be around 6.6 kb long (6562 bp + overlapping regions), while is seems to 
be 10 kb on the gel. This deviation is probably caused by the slower migration of high-
1. Gene Ruler DNA ladder mix (3 µl) 
2. DpnI-treated vector pSOK805 for 
construct 3 (3 µl) 
3. Promoter kefBp for construct 3 (3 µl) 
4. DpnI-treated reporter gusA for 
construct 3 (3 µl) 
 
 1  2  3  4
  
10 kb 
2 kb 
300 bp 
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concentration DNA fragments and GC-rich DNA through the agarose gel. The 
promoter and reporter gene are 300 and 1900 bp in size, respectively.  
The amount of each fragment in the ‘Gibson’ ligation mix is given in Table 2.3.8 and 
the rest of the procedure is presented in Chapter 2.3.11. A negative control mix was 
made by adding the same amount of vector and reporter, but water instead of the 
promoter fragment.  
Electrocompetent E. coli DH10B cells were made as described in Chapter 2.3.8, 
because electroporation is usually a more efficient transformation method. After 
introducing the ‘Gibson’ ligation mix for construct 3 and negative control into E. coli 
DH10B cells by electroporation, a total of 12 colonies appeared and no colonies were 
found on the negative control plate. Plasmid DNA was isolated from the overnight 
cultures and then cut with a restriction enzyme. The colonies were first digested with 
EcoO109I and the resulting fragments were analyzed by gel electrophoresis as shown 
in Figure 3.1.2. 
 
 
Figure 3.1.2: Gel electrophoresis of EcoO109I-digested pDNA from clones transformed with 
‘Gibson’ ligation mix for construct 3. 
The expected band sizes after EcoO109I-digestion of construct 3 and the vector 
template (pSOK805) are given in Table 2.3.14 in Chapter 2.3.12. The second colony 
of construct 3 (c. 3 col. 2) in well 3 has the right restriction pattern. The expected band 
sizes of EcoO109I-digested construct 3 are 6 kb, 2.3 kb and 0.47 kb. The pDNAs in 
well 4-7 are probably the pSOK805 vector template, since the restriction pattern is as 
expected for pSOK805.  
In order to further verify construct 3, it was digested with PstI as well. Gel 
electrophoresis of the DNA fragments resulted in the picture shown in Figure 3.1.3.  
  
1        2        3     4  5       6        7 
8 kb 
5 kb 
3 kb 
0.5 kb 
1. Gene Ruler DNA ladder mix (3 µl) 
2. EcoO109I-digested c. 3 col.1 (3 µl) 
3. EcoO109I-digested c. 3 col.2 (3 µl) 
4. EcoO109I-digested c. 3 col.3 (3 µl) 
5. EcoO109I-digested c. 3 col.4 (3 µl) 
6. EcoO109I-digested c. 3 col.5 (3 µl) 
7. EcoO109I-digested c. 3 col.6 (3 µl) 
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Figure 3.1.3: Gel electrophoresis of PstI-digested pDNA from clones transformed with the 
‘Gibson’ ligation mix for construct 3. 
The expected fragment sizes of PstI-digested construct 3 are 6.7 kb, 1.5 kb and 0.6 kb, 
which correspond well to the bands in well 2. The pDNA in well 3 (construct 3, colony 
3) is clearly pSOK805, since it is similar to the restriction pattern of pSOK805 in well 
4. This second digestion confirmed that clone 2 contains the correct construct 3. 
 
  
  1          2            3          4 
0.6 kb 
1.5 kb 
8 kb 
1. Gene Ruler DNA ladder mix (4 µl) 
2. PstI-digested construct 3, colony 2 
(3 µl) 
3. PstI-digested construct 3, colony 3 
(3 µl) 
4. PstI-digested pSOK805 (3 µl) 
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3.1.2  Assembling construct 4: pSOK805-gusA (negative control) 
Construct 4 was the second plasmid to be successfully assembled and cloned into E. 
coli. The DNA fragments for assembling this negative control vector, were PCR-
amplified and purified as described in Chapter 2.3.4-2.3.7. The fragments were 
analyzed by gel electrophoresis in order to estimate their concentrations (Figure 3.1.4). 
Construct 4 is the negative control which contains only vector and reporter gene. 
 
     
Figure 3.1.4: Gel electrophoresis of the DNA fragments for making construct 4, the negative 
control.  
The DNA fragments is Figure 3.1.4 were assembled by the ‘Gibson’ reaction, as 
explained in Chapter 2.3.11. The ‘Gibson’ reaction mix was transformed into 
electrocompetent E. coli DH10B cells, resulting in a total of 69 clones. Plasmid DNA 
was isolated from 12 clones, PstI-digested and analyzed by gel electrophoresis (Figure 
3.1.5). 
          
Figure 3.1.5: Gel electrophoresis of PstI-digested pDNA from clones transformed with the 
‘Gibson’ ligation mix for construct 4 (negative control).  
8 kb 
2 kb 
1. Gene Ruler DNA ladder mix (3 µl) 
2. DpnI-treated vector pSOK805 for 
construct 4 (3 µl) 
3. DpnI-treated reporter gusA for 
construct 4 (3 µl) 
 
 1   2   3 
  1     2    3    4    5    6    7    8    9  10   11  12   13  14   15    
16 
1.5 kb 
8 kb 
0.6 kb 
Well number: 
1, 14:Gene Ruler DNA 
         ladder mix (3 µl) 
2-13: PstI-digested 
         construct 4 
         colony 1-12  
         (3 µl) 
15:    PstI-digested 
         pSOK805 (3 µl) 
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The restriction pattern in well 10 and 13 correspond well to the expected band sizes of 
PstI-digested construct 4, which are 6.7 kb, 1.2 kb and 0.6 kb. This indicates that the 
isolated pDNA from colony 9 and 12 are the desired construct 4. Most of the other 
restriction patterns resemble the control pSOK805 in well 15, thus they are vector 
templates.  
3.1.3  Assembling construct 1: pSOK805-ermE*p-gusA (positive control) 
Construct 1 consists of the strong constitutive promoter, ermE*p, upstream of the gusA 
reporter gene. This should give constant production of the reporter protein and can 
therefore be used as a positive control when performing the reporter assay. The 
assembly of construct 1 was first tried in a one-step reaction as with the other 
constructs. Since this would not work after several attempts, a new strategy was 
developed. This strategy involved a two-step assembly in which the pSOK805 vector 
and ermE* promoter should first be assembled, resulting in a new vector called 
pSOK807. The new vector should be PCR-amplified to give overlapping terminal 
sequences with the reporter gene. The second assembly should introduce the gusA 
gene downstream of the promoter, to ensure that the promoter regulates expression of 
the reporter gene. New primers for this two-step assembly were designed in j5 
(Hillson) and ordered from Sigma-Aldrich. 
In order to assemble the first vector, pSOK807, the vector template and promoter were 
PCR-amplified and purified. The fragments were analyzed by gel electrophoresis to 
compare their concentrations (Figure 3.1.6). 
 
 
Figure 3.1.6: Gel electrophoresis of the DNA fragments for making pSOK807 (pSOK805-
ermE*p), the first step in the two-step-assembly to make construct 1 (the positive control).  
The fragments in Figure 3.1.6 seem pure and have the same size as the other vector 
and promoter for making construct 3. A ‘Gibson’ ligation mix containing these 
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fragments was transformed into chemically competent E. coli DH10B cells, resulting 
in 12 transformants which were able to grow on selective media. Plasmid DNA was 
isolated from the clones, PstI-digested and analyzed be gel electrophoresis (Figure 
3.1.7). 
 
       
Figure 3.1.7: Gel electrophoresis of PstI-digested pDNA from clones transformed with pSOK807 
(construct 1, step 1) ‘Gibson’ ligation mix.  
The expected band sizes after PstI-digestion of pSOK807 are 4.9 kb, 1.4 kb and 0.6 
kb, while PstI-digestion of the vector template pSOK805 should give two bands of 6.0 
kb and 0.6 kb in size. The pDNA from colony 11 (well 12 on the gel) has the expected 
restriction pattern for pSOK807, thus it is probably the desired plasmid.  
In order to perform the second assembly step and make construct 1, the correct 
pSOK807 isolated from colony 11 was used as template for PCR-amplification of this 
new vector fragment. The reporter gene was also PCR-amplified to give overlapping 
terminal sequences with the vector fragment. The purified fragments were analyzed by 
gel electrophoresis, and the gel picture is given in Figure 3.1.8. 
 
 
 
Figure 3.1.8: Gel electrophoresis of the DNA fragments for assembling construct 1 (the positive 
control) in the second step.  
1. Gene Ruler DNA 
ladder mix (3 µl) 
2. Vector pSOK807 for 
construct 1 (2.2 µl) 
3. Reporter gusA for 
construct 1 (2.2 µl) 
 
10 kb 
2 kb 
1        2                3 
1     2     3    4    5    6     7    8    9   10   11   12   13   14   15 
Well number: 
1, 14: Gene Ruler DNA 
          ladder mix (3 µl) 
2-13:  PstI-digested 
          pSOK807 
          colony 1-12  
          (3 µl) 
15:     PstI-digested 
          pSOK805 (3 µl) 
8 kb 
1.5 kb 
0.6 kb 
53 
 
The vector and reporter fragment in Figure 3.1.8 seem pure, concentrated and have the 
expected size. The ‘Gibson’ ligation mix was transformed into E. coli DH10B and 
EC100 by electroporation and plated on LA with Amp. A total of 44 DH10B clones 
appeared on the plates, while over 200 clones were observed on each plate with EC100 
cells. Plasmid DNA was isolated from 12 clones of each strain, digested with PstI and 
analyzed by gel electrophoresis as shown in Figure 3.1.9 and 3.1.10. 
 
  
Figure 3.1.9: Gel electrophoresis of PstI-digested pDNA from E. coli DH10B clones transformed 
with the ‘Gibson’ ligation mix for construct 1 (positive control), step 2.  
 
   
Figure 3.1.10: Gel electrophoresis of PstI-digested pDNA from E. coli EC100 clones transformed 
with the ‘Gibson’ ligation mix for construct 1 (positive control), step 2. Colony 3, 5, 6 and 11 in 
well 4, 6, 7 and 12 have the right restriction patterns. 
The expected band sizes of PstI-digested construct 1 are 6.7, 1.4, 0.6 and 0.13 kb. This 
particular restriction pattern can be seen in well 9 in Figure 3.1.9 and in well 4, 6, 7 
and 12 in Figure 3.1.10.  These results indicate that 1/12 of the DH10B colonies, and 
as much as 4/12 of the EC100 colonies that were checked, contained the desired 
construct. Some of the other restriction patterns are similar to pSOK807 in Figure 
3.1.7 (well 12), thus the DpnI-treatment was not sufficient in this case. In Figure 
3.1.10, the isolated pDNAs in well 9 and 10 have the expected restriction pattern of the 
reporter gene template (pUC59) and the original vector template (pSOK805), 
respectively.  
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3.1.4  Assembling construct 2: pSOK805-cmlFp-gusA 
Construct 2 contains the cmlF promoter, which controls the expression of the 
chloramphenicol transporter protein. Several attempts to assemble this construct failed, 
and 2 sets of primers were ordered for different strategies. The primer combination 
resulting in proper construction of the vector is given in Attachment C. The purified 
PCR products for a final 1-step assembly of construct 2 were analyzed by gel 
electrophoresis, as shown in Figure 3.1.11. 
 
    
Figure 3.1.11: Gel electrophoresis of the purified DNA fragments for assembling construct 2.  
The vector, promoter and reporter gene fragment in Figure 3.1.11 are pure, 
concentrated and have the expected sizes. These DNA fragments with overlapping 
ends were assembled by the ‘Gibson’ reaction. The reaction mix was transformed into 
E. coli DH10B by electroporation. A negative control ‘Gibson’ ligation mix was made 
of the same amount of fragments, but with water instead of the promoter. The 
transformation mixes were plated out on LA with Amp, and resulted in a total of 13 
colonies, while only 2 colonies appeared on the negative control plate. Plasmid DNA 
was isolated from overnight cultures and digested with PstI restriction enzyme. The 
digested pDNAs were analyzed by gel electrophoresis and the resulting gel picture is 
shown in Figure 3.1.12. 
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Figure 3.1.12: Gel electrophoresis of PstI-digested pDNA from E. coli DH10B clones 
transformed with the ‘Gibson’ ligation mix for construct 2. Colony 2, 3, 5, 8, 9 and 12 in well 3, 
4, 6, 9, 10 and 13 seem to have the right restriction patterns. 
The expected band sizes after PstI-digestion of construct 2 is 6.6, 1.5 and 0.6 kb, 
which corresponds well with 6 out of 13 colonies, considering that concentrated DNA 
migrates slower through the gel than the ladder bands. The remaining 7 colonies are 
pSOK805, since the restriction patterns are similar to the PstI-treated pSOK805 in 
well 16.  
In order to further verify that construct 2 finally was made, the pDNA from colony 2, 
3, 5, 8, 9 and 12 were also digested with AatII and XmaI restriction enzymes. These 
enzymes should cut six times in construct 2, while digestion of the pSOK805 vector 
template only should result in three fragments. All of the expected band sizes after 
enzyme digestion are given in Table 2.3.12-2.3.14 in Chapter 2.3.12. After enzyme 
digestion of the pDNA’s and pSOK805 as control, the fragments were analyzed by gel 
electrophoresis and the result is shown in Figure 3.1.13. 
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Figure 3.1.13: Gel electrophoresis of AatII- and XmaI-digested construct 2, colony 2, 3, 5, 8, 9 
and 12 which seemed right on the previous gel picture. The ladder bands closest to most of the 
DNA fragments are indicated to the left and the content in each well is specified to the right. 
The fragment sizes after AatII-digestion of construct 2 are as expected (3.5 kb, 2.7 kb, 
1.0 kb, 0.8 kb, 0.5 kb and 0.25 kb). The XmaI-digested construct 2 also have the 
expected fragment sizes as given in Table 2.3.13. The expected fragments after XmaI-
digestion of pSOK805 (3.4 kb, 3.1 kb and 0.1 kb) correspond well with the bands seen 
in well 16, considering that the double-band was not sufficiently separated during gel 
electrophoresis. These results confirm that construct 2 finally was assembled. 
 
A summary of the transformations that led to isolation and verification of the correct 
constructs is given in Table 3.1.1. The vectors with their respective promoters are 
listed in this table. The number (#) of colonies that appeared after transformation into 
the specific strains are also listed, as well as how many correct constructs that were 
verified from the isolated plasmid DNA. 
Table 3.1.1: Summary of the transformation and verification of the four constructs. The total 
number (#) of colonies that appeared after transformation, number of isolated plasmid DNA and 
how many correct constructs that were among them are listed in this table. 
Vector Promoter 
E. coli 
strain 
Transformation 
method 
# 
colonies 
# isolated 
pDNA’s 
# correct 
constructs 
pSOK807 ermE*p DH10B heat-shock 12 12 1 
construct 1 ermE*p DH10B electroporation 44 12 1 
construct 1 ermE*p EC100 electroporation > 500 12 4 
construct 2 cmlFp DH10B electroporation 13 13 6 
construct 3 kefBp DH10B electroporation 12 6 1 
construct 4 - DH10B electroporation 69 12 2 
 
  
1     2    3    4    5    6     7    8    9   10  11   12  13  14  15  16 
Well number: 
8, 15: Gene Ruler DNA 
          Ladder mix (3 µl) 
1-6: AatII-digested 
       c. 2, col. 2, 3, 5, 8, 9 
       and 12 (3 µl) 
7:    AatII -digested 
       pSOK805 (3 µl) 
9-14: XmaI-digested 
       c. 2, col. 2, 3, 5, 8, 9 
       and 12 (3 µl) 
16:  XmaI-digested 
       pSOK805 (3 µl) 0.1 kb 
0.3 kb 
0.6 kb 
1 kb 
1.2 kb 
3.5 kb 
5 kb 
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3.2 TRANSFERRING THE CONSTRUCTS INTO S. VENEZUELAE 
In order to transfer the constructs into S. venezuelae, the vectors were first introduced 
into chemically competent E. coli ET12567 cells by transformation. ET cells with the 
constructs were mixed with heat-shocked spores of S. venezuelae to promote 
conjugative transfer of pDNA into the genome of S. venezuelae. The detailed 
mechanism for conjugative DNA transfer is described in Chapter 1.5.3, while the 
laboratory procedure is described in Chapter 2.3.13.  
The conjugative transfer of construct 3 (pSOK805-kefBp-gusA) was performed by 
using fresh S. venezuelae spores, and the cell mix was grown at room temperature for 
15 hours prior to selection with antibiotics. Some transconjugants appeared six days 
after selection and were then transferred onto ISP4 plates supplemented with nalidixic 
acid (Nal) and thiostrepton (Thio). Colonies which were able to grow on selective 
media were distributed over an ISP4 plate with Thio in order to make a glycerol stock 
of the strain.  
Construct 4 (negative control) was transferred into S. venezuelae from a frozen 
glycerol stock. Selection for transconjugants was performed 15 hours after plating the 
cell suspension. The plates were placed at 30 °C for further growth, and after 15 days 
one small colony was observed. This colony was transferred onto ISP4 medium with 
Nal and Thio to select further, and 11 days later, colonies with Streptomyces 
morphology was observed. Since only one transconjugant arised from the first 
conjugation with construct 4, a second conjugation was performed, this time with fresh 
spores of S. venezuelae. The plates had a matt white surface when selection of 
transconjugants was performed 16 hours after plating the cell suspension. One week 
after selection, transconjugants were transferred onto ISP4 with Nal and Thio for 
further selection, followed by final selection on ISP4 with Thio. 
The conjugative transfer of construct 1 (positive control) into S. venezuelae did not 
result in any well-growing clone even after 3 independent conjugations with fresh 
spore suspensions. During the conjugations, the mixtures of donor cells and recipient 
spores were grown for 16 hours at room temperature before Nal and Thio was 
distributed over the plates to select for transconjugants. One week after selection, some 
colonies were transferred onto ISP4 plates supplemented with Nal and Thio for further 
selection, but they did not grow after six days of incubation. The original colonies on 
the conjugation plate were yellow and did not have the characteristic morphology of S. 
venezuelae, indicating that they were not real recombinant strains with construct 1. 
This can be due to the wrong choice of ET cells, which maybe did not contain 
construct 1. 
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Construct 2 (pSOK805-cmlFp-gusA) was introduced into S. venezuelae by growing the 
mixtures of donor cells and recipient spores for 19 hours prior to selection with 
antibiotics. Several recombinant strains appeared four days after selection, and were 
selected further by growth on selective media.  
In summary, the biosensor constructs number 2 and 3, as well as the negative control 
construct number 4 were introduced into the genome of S. venezuelae by conjugative 
DNA transfer from E. coli ET12567, resulting in recombinant strains. Construct 1 
(positive control) was however not successfully introduced into S. venezuelae even 
after 3 independent attempts.  
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3.3 ANALYSIS OF CML PRODUCTION IN CULTURE BROTH  
Recombinant S. venezuelae strains with introduced construct 2, 3 and 4 were cultured 
low-production medium to test the sensitivity of the biosensors. Ethanol was added to 
half of the cultures 10 hours after inoculation and 12 hours before the first samples 
were collected on day 1. The procedure for Cml extraction and preparation for UPLC 
analysis is described in Chapter 2.3.14. 
After pelleting the cells by centrifugation, it was observed about 4-5 times more cells 
in the samples from cultures without ethanol, than from the cultures with ethanol. This 
indicates that addition of ethanol inhibits cell growth significantly. The cell 
concentration affects the amount of GusA enzyme in the cell lysates and may also 
affect the Cml production level. Cml was extracted from the cell supernatant by ethyl 
acetate, which was later evaporated. The residue was dissolved in methanol and 
analyzed by UPLC. Raw data from the UPLC analysis is given in Attachment G (page 
88), while the calculation of final Cml concentration in µg/ml is described in Chapter 
2.3.14. The mean Cml concentration in each culture is presented in Figure 3.3.1 and 
the error bars indicate the standard deviation of the mean (SDOM). 
 
Figure 3.3.1: Chloramphenicol production in S. venezuelae transconjugants with introduced 
construct 2 (cmlFp), 3 (kefBp) and 4 (noPro). The strains were cultured with and without 
addition of ethanol (EtOH), and three parallel samples were taken from each culture on day 1 
and 4 after inoculation.  
The results from this first experiment are mostly not as expected. Addition of ethanol 
to the cultures should stop the production of Cml. The opposite is observed for the S. 
venezuelae transconjugant with introduced construct 2, which also shows a particularly 
low Cml productivity.  
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Chloramphenicol biosynthesis in the recombinant strain with construct 3 cultured with 
ethanol, seems to begin already before the first samples were collected on day one. 
Finally, on day 4 there was no difference in Cml production by this strain growing 
with or without ethanol shock, even though biosynthesis in the non-shocked strain 
started later. This may indicate that addition of ethanol decreased the rate of Cml 
production in this strain, since the non-shocked strain produced more Cml from day 1 
to day 4 than the ethanol-shocked strain did during these days. 
The only recombinant strain showing expected Cml production under different 
conditions is the strain that contains construct 4, which has no promoter controlling the 
gusA reporter gene. This strain showed low Cml production in the culture with ethanol 
added and high Cml production in cultures without ethanol. Unfortunately, this was 
not a biosensor strain, but a negative control strain for the reporter assay, so the Cml 
production could not be correlated to the GusA enzyme activity. 
The Cml titer is expected to increase with longer production time, and this is also the 
case for all of the recombinant strains shown in Figure 3.3.1. Some of the strains show 
less difference in produced Cml than others, but there is an overall increase in Cml 
produced from day 1 to day 4. The recombinant strain with construct 3 shows the 
highest increase in Cml concentration from day 1 to day 4 in the culture without 
ethanol. Negligible amounts of Cml was produced until day 1, compared to the higher 
Cml concentration on day 4, which indicates that the onset of Cml production was 
induced later than for the other strains.  
The total Cml production titer in this experiment is low compared to Cml yields 
reported previously by others. S. venezuelae wild-type strain cultured in medium 
containing glucose (3 % w/v), isoleucine (0.75 %) and basal salts produced 50 µg/ml 
Cml after three days of growth (Xu et al., 2010b). In comparison, the highest Cml 
concentration achieved in this experiment was 1.5 µg/ml after 4 days of growth. This 
deviation is probably due to the low-production medium used in this experiment in 
order to investigate the sensitivity of the biosensors. More experiments should be 
performed with other media, in order to increase the Cml production levels. 
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3.4 RESULTS FROM THE REPORTER ASSAY 
The samples collected from the cultures were frozen down until the reporter assay 
analysis was performed, as described in Chapter 2.3.15. The cells were lysed to release 
the intracellular GusA enzyme, which converts PNPG substrate to a chromogenic 
compound that has maximum absorbance at 405 nm (Aich et al., 2001). The PNPG 
substrate was added to the cell lysates and incubated at 37 °C for 40 minutes until the 
optical density (OD) was measured in a spectrophotometer at 415 nm and 405 nm of 
light wavelength. The plate was left at room temperature for about 17 hours before 
new measurements were performed the next morning. These last results are presented 
graphically in Figure 3.4.1 and 3.4.2, and the OD measurements are given in 
Attachment H (page 89).  
 
Figure 3.4.1: Glucuronidase activity measured as OD405 in cell lysates of S. venezuelae 
transconjugants with introduced construct 2 (cmlFp), 3 (kefBp) and 4 (noPro), which were 
cultured with and without addition of ethanol (EtOH). The error bars indicate the means ± 1 
SDOM. 
The results from OD405 and OD415 analysis have similar trends, although the OD405 
measurements are about 0.02 values higher than the OD415 measurements. This is in 
agreement with the fact that the maximum absorbance of p-nitrophenol (one of the 
reaction products) is at 405 nm (Aich et al., 2001). The absorbance at 415 nm was also 
measured since this wavelength was used by Myronovskyi et al. (2011) when PNPG 
was used as a substrate for glucuronidase. 
 
-0,02
0
0,02
0,04
0,06
0,08
0,1
0,12
0,14
0,16
1 4
OD405 
Day 
c.2: EtOH added
c.2: no EtOH
c.3: EtOH added
c.3: no EtOH
c.4: EtOH added
c.4: no EtOH
Blank
62 
 
 
Figure 3.4.2: Glucuronidase activity measured as OD415 in cell lysates of S. venezuelae 
transconjugants with introduced construct 2 (cmlFp), 3 (kefBp) and 4 (noPro). The strains were 
cultured with and without addition of ethanol (EtOH) as indicated to the right. The error bars 
indicate the means ± 1 SDOM.  
The samples collected on day 1 show lower enzyme activity in the cultures with 
ethanol, than in those without. This deviation may be due to the much lower cell 
concentration in the samples added ethanol, since the GusA concentration in the lysate 
is proportional to the amount of cells. In future experiments, the enzyme activity 
should be adjusted and correlated to the protein concentration in the lysates in order to 
get comparable results.  
 Construct 4 lacks a promoter for the gusA gene and is therefore considered as a 
negative control. Unexpectedly, the glucuronidase activity in lysate from the 
recombinant strain with construct 4 is as high as the activity of lysate from the strain 
with construct 2 (on day 1). This may be due to read-through from a promoter in the 
genome of S. venezuelae at the site of construct integration.  
The S. venezuelae recombinant strain with introduced construct 3 (kefBp) showed the 
highest glucuronidase activity. The activity increases from the first day until the fourth 
day, which corresponds to the higher Cml concentration achieved on day 4. However, 
the increase in Cml production from day 1 to day 4 does not fully correlate with the 
increase in GusA activity. Several experiments are required to verify this trend. 
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4  GENERAL DISCUSSION 
4.1 CONSTRUCTION AND VERIFICATION OF THE VECTORS 
While analyzing the overlapping fragments for ‘Gibson’ ligation by gel 
electrophoresis, a deviation from the expected band size was observed for the largest 
fragments. This may be due to the slower migration rate of GC-rich DNA and 
fragments with higher concentration than the ladder band.  
DpnI treatment of PCR products is used to digest methylated PCR templates and retain 
the un-methylated PCR product. Common E. coli strains Dam-methylate their DNA, 
which is therefore susceptible to the DpnI digestion (Weiner et al., 1994). During 
verification of the constructs, many of the isolated pDNA’s were identified as original 
vector or reporter gene plasmid templates. This insufficient digestion of methylated 
DNA templates may be due to high template concentrations compared to the enzyme 
concentration, or too short digestion times. Dilution of the PCR-template was probably 
the most efficient approach in order to reduce pDNA templates in the transformants, 
since longer DpnI treatment was used for several other fragments without eliminating 
the templates completely.  
Verification of the constructs can also be performed by DNA sequencing in order to 
ensure that no mutations had occurred in important parts of the vector. A mutation in 
the origin of transfer, attachment site or integrase gene could affect the conjugative 
transfer of DNA and result in no transconjugants, while mutations in the inserted 
promoters and/ or gusA gene could result in unexpected reporter assay results.  
4.2 CONJUGATIVE DNA TRANSFER 
Optimization of the conjugation protocol for streptomycetes is in progress, and the 
protocol was recently changed. The main differences between the protocol used for the 
project work and this Master thesis are: (i) centrifugation of the bacterial mix to 
achieve better cell-to-cell contact, (ii) overnight incubation at room temperature 
instead of 30 °C, (iii) letting the antibiotic suspension diffuse into the plate with the lid 
closed instead of drying it with an open lid inside the sterile hood. 
A critical point in the conjugation procedure is the selection of transconjugants by 
adding a solution of nalidixic acid and thiostrepton to the plate. Thiostrepton was used 
to select for recombinant strains with the inserted constructs, while nalidixic acid was 
used to select against E. coli since streptomycetes are naturally resistant. If the 
antibiotic mix is added too early in the growth phase, it will probably affect the 
outcome, since the bacteria needs to be robust to survive the antibiotic stress imposed 
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upon them. After using trial-and-error method it was observed that more 
transconjugants were obtained when the antibiotic solution was added after a visible 
layer of mycelia had appeared on the plate. 
4.3 CHLORAMPHENICOL PRODUCTION IN CULTURED STRAINS 
In order to achieve higher Cml production, different growth conditions for S. 
venezuelae should be tested in future experiments. Cml production has been reported 
to depend on the combination of carbon- and nitrogen source in the growth medium 
(Doull and Vining, 1990) and nitrogen sources that resulted in a slow, controlled 
growth  (e.g. DL-Serine) were shown to increase the Cml yield (Westlake et al., 1968). 
A common medium used to promote Cml biosynthesis contains glucose (3 % w/v), 
isoleucine (0.75 %) and basal salts (Doull et al., 1985, Brown et al., 1996, Facey et al., 
1996). In this experiment, a low-production medium containing maltose, yeast extract 
and malt extract was used in order to test the sensitivity of the biosensors. Other media 
and growth conditions may be tested in future experiments.  
4.4 REPORTER ASSAY 
The GusA activity was investigated by incubating the PNPG substrate with cell lysates 
from the recombinant strains that were cultured under different conditions. Enzyme 
concentration in cell lysates is expected to be proportional to the amount of cells. The 
cell concentration in cultures without ethanol was 4-5 times larger than in the cultures 
added ethanol, thus the protein content must be adjusted in order to give comparable 
results. The results from this first reporter assay are therefore preliminary. Future 
experiments should also include the positive control construct and measurements of 
protein content in the cell lysates, in order to compare the enzyme activities measured 
in the reporter assay. 
Other sources of error in the reporter assay may be caused by freezing down the 
samples collected from the cell cultures, since it is unknown whether the enzyme 
tolerates to be stored at -20 °C. Another source of error may be insufficient lysis of the 
cells, which results in less GusA enzyme in the cell lysate. It may also be that storing 
the lysate at room temperature, instead of on ice, can influence the enzyme activity and 
thus also the OD measurements. The reporter assay protocol can be developed to 
circumvent such sources of error and perhaps lead to better results. The main source of 
error during the OD measurements was bubbles in the wells: light reflection from the 
bubble surface may have affected the measured absorbance. Careful pipetting can 
reduce the amount of bubbles in future experiments.  
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4.5 FUTURE WORK 
The positive control for the reporter assay, construct 1, remains to be introduced into 
S. venezuelae. Modified versions of the conjugation protocol, as well as using other 
colonies of E. coli ET12567 cells containing the construct, may result in site-specific 
integration of the construct into the genome of S. venezuelae. However, if future 
observations indicate that the strong ermE* promoter inhibits cell growth by 
constitutive expression of the GusA enzyme, an inducible promoter may be used 
instead. Examples of inducible promoters used in streptomycetes are: tipA, which is 
induced by addition of thiostrepton, and tetR, which is induced by tetracycline and 
anhydrotetracycline (Medema et al., 2011b). The limitation with these inducible 
systems is that they are leaky. Low-level transcription from the promoter occurs even 
in the absence of an inducer (Myronovskyi et al., 2011).  
The culturing of transconjugant strains should be repeated and different culture 
conditions can be tested, as discussed previously. The positive control construct should 
be included and the protein content in lysates should be measured to get comparable 
results from the reporter assay.  
If future experiments result in the expected correlation between Cml production and 
GusA activity in the strains containing biosensor constructs, this model may be used to 
detect when silent gene clusters are expressed. New biosensors may be constructed by 
fusing promoters that control transporter gene expression in silent secondary 
metabolite gene clusters to the gusA reporter gene. Expression of the transporter gene 
may be detected by the reporter assay, since the genes are placed under the same 
regulatory control mechanisms. This may help to detect under which conditions 
expression of a silent secondary metabolite gene cluster is activated, which may result 
in the discovery of new drugs.   
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5  CONCLUSION 
The four vectors were successfully assembled by the ‘Gibson’ reaction and verified by 
enzyme digestion followed by gel electrophoresis. Three out of four constructs were 
site-specifically integrated into the genome of S. venezuelae by conjugative DNA 
transfer from E. coli ET12567. The recombinant strains were verified by further 
selection with antibiotics. 
Culturing of the S. venezuelae recombinant strains in low-production medium was 
followed by the reporter assay and detection of chloramphenicol production by UPLC 
analysis. One of the biosensor strains showed a correlation between production of 
chloramphenicol and the reporter assay results, but this trend needs to be verified by 
further experiments. The results from the reporter assay are preliminary, since the 
protein content has to be adjusted when measuring enzyme activity in the lysates. The 
cells produced only small amounts of chloramphenicol, thus different media and 
culture conditions should be tested in future experiments. Several independent 
experiments are required before any final conclusions can be drawn on the 
functionality of the biosensors. 
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ATTACHMENT A: MEDIA RECIPES 
A1 LB medium 
LB medium for bacterial growth in liquid culture was prepared by weighing out the 
ingredients listed in Table A1. The ingredients were dissolved in distilled water, and 
then autoclaved at 121 °C for 20 min. 
Table A1: Recipe for making LB-medium.  
Ingredients 
Concentration 
[g/L] 
Tryptone 10 
Yeast extract 5 
NaCl 5 
 
A2 LA medium 
The prescription on how to prepare LA medium for bacterial growth on a solid plate is 
given in Table A2. The ingredients were dissolved in distilled water before 
sterilization at 121 °C for 20 min. Different antibiotic(s) were added to the medium 
when it had cooled down to 50-60 °C: 1µl antibiotic stock solution per 1 ml LA 
medium. The solution was mixed well before distributing the hot liquid into plates. 
Table A2: Recipe for making LA medium. 
Ingredients 
Concentration 
[g/L] 
Tryptone 10 
Yeast extract 5 
NaCl 5 
Agar 15 
 
A3 ISP4 medium 
ISP4 medium for Streptomyces growth and conjugation was prepared as suggested on 
the package (Difco ISP Medium 4): 37 g media/L distilled water. The mixture was 
autoclaved at 121 °C for 20 min. MgCl2 was added to some of the ISP4 medium (1 ml 
1 M MgCl2 / 100 ml ISP4 medium) to increase the conjugation efficiency. ISP4 plates 
with only thiostrepton, and some with both nalidixic acid and thiostrepton were also 
made. The final concentration of each antibiotic was in both cases 30 µg/ml medium. 
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A4 TSB medium 
Tryptone Soya Broth (TSB) medium for culturing Streptomyces was prepared as 
suggested on the package: 30 g/L distilled water. The mix was autoclaved at 121 °C 
for 20 min. 
 
A5 2YT medium 
The 2×YT medium for conjugation between Streptomyces venezuelae and E. coli 
ET12567 was prepared by adding the ingredients listed in Table A5 to 9/10 of the total 
volume distilled water. Then the pH was adjusted to 7.0 by adding 5 M NaOH. The 
volume was adjusted to 1L with distilled water before sterilization at 121 °C for 20 
min. 
Table A5: Recipe for 2YT medium. 
Ingredients 
Concentration 
[g/L] 
Bacto Tryptone 16 
Bacto Yeast extract 10 
NaCl 5 
 
A6 MYM medium 
The MYM medium for culturing Streptomyces was prepared my mixing the 
ingredients listed in Table A6 with 1 L distilled water before autoclaving the medium 
at 121 °C for 20 min. 
Table A6: Recipe for MYM medium 
Ingredients 
Concentration 
[g/L] 
Maltose 4 
Yeast extract 4 
Malt extract 10 
MOPS Na-salt 1,9 
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ATTACHMENT B: BUFFERS AND STOCK SOLUTIONS 
B1 TSS buffer 
The TSS buffer is used to prepare chemically competent cells. It was made by adding 
the three first ingredients in Table B1, adjusting the pH to 6,5 and autoclaving before 
addition of DMSO. 
Table B1: Recipe for TSS buffer. 
Ingredients Total concentration Amount for 50 ml buffer 
LB-media 85 % 42.5  ml 
PEG6000 10 % 5 g 
MgCl2 (1 M) 20 mM 2.5 ml 
DMSO 5 % 2.5 ml 
 
B2 50 TAE buffer 
TAE buffer is used for DNA gel electrophoresis. The 50 TAE buffer was made 
according to the recipe in Table B2, and diluted to 1× TAE buffer.  
Table B2: Recipe for 50 TAE buffer. 
Ingredients Amount 
Tris-base 242.0 g 
Acetic acid (100 %) 57.1 ml 
EDTA (0.5 M) pH 8 100 ml 
ds H2O up to 1 L total volume 
 
B3 Agarose (0,8 %) 
Agarose solution for gel electrophoresis was made by mixing the ingredients in Table 
B3 together and warming it in the microwave for 5 min until the powder was dissolved 
and the solution was clear. The agarose solution was stored at 60 °C. 
Table B3: Recipe for agarose solution (0,8 %). 
Ingredients Amount 
SeaKem LE Agarose 2.4 g 
1 TAE buffer 300 ml 
GelGreen Nucleic Acid Stain (10 000) 30 µl 
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B4 Glycerol stock solution (20 %) 
The 20 % Glycerol solution was made by diluting glycerol solution (99.5 %) in 
distilled water with ratio 1: 5 as indicated in Table B4. 
Table B4: Recipe for 20 % Glycerol stock solution. 
Ingredients 
Concentration 
[ml/L] 
Glycerol (99.5 %) 200 
distilled H2O 800 
 
B5 Lysozyme (10 %) in EDTA 
A 10 % Lysozyme solution was made by mixing the ingredients listed in Table B5. 
Table B5: Recipe for 10 % Lysozyme in EDTA. 
Ingredients Amount for 5 ml 
Lysozyme 0.05 g 
EDTA (50 mM, diluted  from 0.5 M) 5 ml 
 
B6 Antibiotic stock solutions 
All the antibiotic stock solutions were made by dissolving proper amount of the 
antibiotic salt in a solvent. The ingredients are listed in Table B6.1 - B6.5. All the 
antibiotics were stored at - 20 °C. 
Table B6.1: Ampicillin stock solution (100 mg/ml dsH2O). 
Ingredients Amount 
Ampicillin 0.5 g 
dsH2O 5 ml 
Table B6.2: Chloramphenicol stock solution (30 mg/ml dsH2O). 
Ingredients Amount 
Chloramphenicol 150 mg 
Absolute ethanol 5 ml 
Table B6.3: Kanamycin stock solution (40 mg/ml dsH2O). 
Ingredients Amount 
Kanamycin 200 mg 
dsH2O 5 ml 
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Table B6.4: Nalidixic acid stock solution (30 mg/ml 0.1 M  NaOH). 
Ingredients Amount 
Nalidixic acid sodium salt 150 mg 
NaOH (0.1 M) 5 ml 
 
Table B6.5: Thiostrepton stock solution (30 mg/ml DMSO). 
Ingredients Amount 
Thiostrepton 150 mg 
DMSO 5 ml 
 
B7 ‘Gibson’ reaction solutions 
The recipes for the Gibson 5× isothermal reaction buffer and Gibson ligation master 
mix are given in Table B7.1 and B7.2, respectively. 
Table B7.1: Gibson 5× isothermal reaction buffer. 
Ingredients Amount 
Tris-HCl (1 M) 3 ml 
MgCl2 (2 M) 150 µl 
dGTP (100 mM) 60 µl 
dATP (100 mM) 60 µl 
dTTP (100 mM) 60 µl 
dCTP (100 mM) 60 µl 
DTT (1 M) 300 µl 
Polyethyleneglycol (PEG-8000) 1.5 g 
NAD (100 mM) 300 µl 
Table B7.2: Gibson ligation master mix. 
Ingredients Amount 
5 × isothermal reaction buffer 80 µl 
T5 exonuclease (1 U/µl, diluted 10x from 10 U/µl) 1.6 µl 
Phusion DNA polymerase 5 µl 
Taq DNA ligase 40 µl 
dsH2O 174.4 µl 
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B8 Buffers for the reporter assay 
Recipes for buffers used in the reporter assay are given in Table B8.1- B8.6. The 
sodium phosphate buffer was adjusted to pH 7.0 before it was used to prepare the 
dilution buffer.  
Table B8.1: Recipe for making the sodium phosphate buffer (100 mM, pH 7.0). 
Ingredients Amount [ml] 
Na2HPO4 (1 M) 5.78 
NaH2PO4 (1 M) 4.24 
dsH2O 90 
Total volume 100 
This phosphate buffer was used as a basis to make the dilution buffer as described in 
Table B8.2. The DTT (1 M) and Triton X-100 (10 %) solutions were made prior to 
making the dilution buffer. The dilution buffer was autoclaved at 120 °C for 20 min to 
sterilize it. 
Table B8.2: Recipe for making the dilution buffer. 
Ingredients 
Total 
concentration Amount 
Phosphate buffer (100 mM, pH 7,0) 50 mM 100 ml 
Dithiothreitol (DTT,  1M) 5 mM 1 ml 
Triton-X-100 (10 %) 0,1 %  2 ml 
dsH2O 
 
97 ml 
Total volume   200 ml 
The sterilized dilution buffer was used to make the lysis buffer, which was prepared 
fresh right before use by mixing the ingredients in Table B8.3. 
Table B8.3: Recipe for making the lysis buffer (1 mg lysozyme/ml dilution buffer). 
Ingredients Amount 
Dilution buffer 58 ml 
Lysozyme 0.0577 g 
A stock solution of p-nitrophenyl-β-D-glucuronide (PNPG) substrate for the reporter 
assay was also freshly prepared by mixing the ingredients listed in Table B8.4. 
Table B8.4: Recipe for making PNPG substrate stock solution (0.2 M). 
Ingredients Total concentration Amount 
p-nitrophenyl-β-D-glucuronide (PNPG) 0.2 M 0.0323 g 
Sodium phosphate buffer (100 mM, pH 7.0) 50 mM 256 µl 
dsH2O 
 
256 µl 
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ATTACHMENT C: PRIMERS 
The primers were designed in j5 (Hillson). 
Construct 1: pSOK805::ermEp::gusA assembled in two steps 
1) Assembling pSOK807 (pSOK805 + ermEp)  
SOK805e-F:       GATCTGCAGCCAAGCGATGAATTCGTAATCATGGTCATAGC 
SOK805e-R:    GAGCTCGAATTCCGATATCTAGATCTCGAGCTCGCG  
ermEp7-F:       AGATCTAGATATCGGAATTCGAGCTCGGTACC  
ermEp7-R:       GATTACGAATTCATCGCTTGGCTGCAGATCCTACC 
2) Assembling construct 1 (pSOK807 + GusA) 
SOK807-F:  CCGGTATCCGACCGATGAATTCGTAATCATGGTCATAGC 
SOK807-R:  CCGGCCTCAGCATGCTTGGCTGCAGATCCTACC 
GusA7-F:    TCTGCAGCCAAGCATGCTGAGGCCGGTCGAG  
GusA7-R:    TTACGAATTCATCGGTCGGATACCGGTGGAAAC 
Construct 2: pSOK805::cmlFp::gusA 
SOK805-F1:   use SOK805_kef-F 
SOK805-R1:  TGTTCATGACGACCCGAAGTTCACCGAAGAGC 
cmlFpN-F:   CGGTGAACTTCGGGTCGTCATGAACACTCCTTCTCC 
cmlFpN-R2:  CCGGCCTCAGCATGAATTCCGACGTTCCCTGG 
GusAcp-F1:  AACGTCGGAATTCATGCTGAGGCCGGTCGAG 
GusAcp-R1:          GGAATTGTGAGCGGATAACGGTCGGATACCGGTGGAAAC 
 
Construct 3: pSOK805::kefBp::gusA 
SOK805_kef-F:    CCGGTATCCGACCGTTATCCGCTCACAATTCCACAC  
SOK805_kef-R:    ATCTACGTTCTCGCCGAAGTTCACCGAAGAGC  
KefBp-F:          CGGTGAACTTCGGCGAGAACGTAGATGGCGAATGG  
KefBp-R:         CCACAGGTCTCAGCATGAACACTCCTTCTCCGCG  
GusA_kef-F:    AGAAGGAGTGTTCATGCTGAGACCTGTGGAAAC  
GusA_kef-R:          GGAATTGTGAGCGGATAACGGTCGGATACCGGTGGAAAC 
 
Construct 4: pSOK805::gusA (NoPro) 
SOK805n-F:   use SOK805kef-F 
SOK805n-R:    GGTTGGTGACTGCCCGAAGTTCACCGAAGAGC  
SD_gusA-F:   CGGTGAACTTCGGGCAGTCACCAACCGCATC 
GUSAn-R:              GGAATTGTGAGCGGATAACGGTCGGATACCGGTGGAAAC  
SD_gusA-F + GUSAn-R 
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ATTACHMENT D: PLASMID MAPS 
The plasmid maps with relevant restriction sites are presented in Figure D1-D5. All the 
plasmids contain a bla gene which confers resistance to ampicillin, and most of the 
plasmids contain a gusA gene which encodes the reporter enzyme (β-glucuronidase). 
The constructs in Figure D3-D5 and pSOK805 in Figure D1 contain: RP4 oriT, origin 
of conjugal transfer; attP, attachment site; int, integrase gene; ColElori, origin of 
replication in E. coli; tsr, thiostrepton resistance gene for selection of S. venezuelae 
transconjugants.  
 
 
 
 
Figure D3: Left: the intermediate (pSOK807) plasmid when constructing the positive control 
vector in two steps. Right: construct 1 (positive control). 
Figure D2: Template plasmid for the gusA 
reporter gene. It also contains a bla gene 
which confers resistance to ampicillin.
 
Figure D1: Template vector for construction of 
the biosensors. 
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Figure D4: The biosensor plasmids. Construct 2 to the left, construct 3 to the right. 
 
 
Figure D5: The negative control construct 4 without any promoter upstream of the gusA 
reporter gene.  
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ATTACHMENT E: GEL ELECTROPHORESIS LADDER 
The ladder used in gel electrophoresis is shown in Figure E1. 
 
Figure E1: The band sizes of Gene Ruler 1 kb DNA ladder mix from Fermentas. 
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ATTACHMENT F: STANDARD LAB PROTOCOLS 
F1 Isolation of genomic DNA  
The protocol for isolation of genomic DNA with Wizard® Genomic DNA Purification 
Kit from Promega is described below. 
1. 1,5 ml of an overnight culture was transferred to an Eppendorf tube and 
centrifuged (13 000 rpm, 4 min). 
2. The supernatant was removed and the cells were resuspended in 600 μl of 
lysozyme (10 % in 50mM EDTA) and then incubated at 37 °C for 30 – 60 min. 
Lysozyme inhibits the cross-bonding in peptidoglycan, thus weakening the cell 
wall of Gram positive bacteria. 
3. After incubation, the suspension was centrifuged under the same conditions and 
the supernatant was removed. 
4. The cells were gently resuspended in 600 μl of Nuclei Lysis Solution. This mix 
was incubated at 80 °C for 5 min to lyse the cells, and then cooled down to 
room temperature. 
5. RNase Solution (3 µl) was added, and mixed by inverting the tubes 4 times. It 
was incubated at 37°C for up to 60 min, before cooling it down to room 
temperature. 
6. Proteins were precipitated from the solution by adding Protein Precipitation 
Solution (200 µl) and vortexing for 20 seconds. 
7. The sample was incubated on ice for 5 min, and centrifuged (13 000 rpm, 3 
min). 
8. The supernatant was transferred to a clean Eppendorf tube containing 600 μl of 
isopropanol. The solution was gently mixed by inversion until DNA 
precipitated. 
9. When DNA had formed a visible mass, the tube was centrifuged again (13 000 
rpm, 2 min). The supernatant was discarded and the tube was drained on 
absorbent paper. 
10. Ethanol (600μl, 70 %) was added and the tube was mixed by inversion to wash 
the DNA pellet. 
11. The sample was centrifuged (13 000 rpm, 3 min) and the ethanol was carefully 
aspirated. 
12. The tube was drained on absorbent paper and the pellet was air-dried for 10-15 
min. 
13. The DNA-pellet was rehydrated by adding 100 μl DNA Rehydration Solution 
and incubating it at 65°C for 1 hour.  It was mixed several times during 
incubation by tapping the tube. 
14. Purified genomic DNA was stored at -20 °C. 
85 
 
F2 Isolation of DNA fragments from agarose gel  
QIAquick Gel Extraction Kit: 
The protocol for isolation of DNA from agarose gel by using QIAquick Gel Extraction 
Kit from QIAGEN is described below. 
1. The DNA band was cut from the gel with a clean, sharp scalpel while 
visualized by trans UV-light in Gel Doc 2000. 
2. The gel slice was weighed and added 3 volumes of Buffer QG to 1 volume of 
gel in an Eppendorf tube (ml Buffer QG = 3* mg of gel). 
3. The solution was incubated at 50 °C until the gel was dissolved. 
4. The solution was yellow which indicated right pH for optimal DNA binding. If 
the solution had been orange or violet, 10 µl of 3 M sodium acetate should be 
added to achieve pH ≤ 7.5. 
5. One gel volume of isopropanol was added to increase the yield of DNA 
fragments, and mixed by vortexing. 
6. The mix was transferred to a QIAquick spin column in a collection tube and 
centrifuged for 1 min at full speed. 
7. The flow-through was discarded, and Buffer QG (500 µl) was added to remove 
all traces of agarose. The tube was centrifuged again and the flow-through was 
discarded. 
8. Buffer PE (750 µl) was added to wash the DNA. The column was centrifuged, 
the flow-through discarded and a second centrifugation was performed (1 min, 
full speed). 
9. The spin column was transferred to a clean Eppendorf tube and warm (50°C) 
Buffer EB (30 µl) was added to elute DNA. The tube was centrifuged again. 
10. The purified DNA was stored at -20°C, and a small amount of it was checked 
by gel electrophoresis. 
QIAEX II Suspension: 
The QIAEX II suspension contains silica particles which absorb DNA in the presence 
of high salt solution. Impurities like agarose, proteins and salts are removed during the 
washing steps, while nucleic acids are bound to the silica particles. The protocol for 
isolation of DNA from agarose gel by using QIAEX II suspension from QIAGEN is 
described below. 
1. The DNA band was cut from the gel with a clean, sharp scalpel while 
visualized by trans UV-light in Gel Doc 2000. 
2. The gel slice was weighed and added 3 volumes of Buffer QG to 1 volume of 
gel in an eppendorf tube (ml Buffer QG = 3*mg of gel).  
3. QIAEX II suspension (10 µl) was added to the tube and mixed well by 
vortexing (for fragments < 10 kb) or flicking the tube (for isolation of larger 
86 
 
fragments > 10 kb). The solution was incubated at 50 °C for 10 min, while 
flicking the tube once in a while to mix and enhance DNA-absorption by the 
silica particles in the QIAEX II suspension. 
4. The tube was centrifuged at top speed for 30 seconds, before aspirating the 
supernatant with a pipette. Buffer QG (500 µl) was added to the pellet and 
resuspended by flicking the tube gently. 
5. Step 4 was repeated two times with 500 µl of Buffer PE. 
6. The tube was centrifuged at top speed for 30 seconds, and the supernatant was 
removed with a thin pipette to take out as much liquid as possible. The pellet 
was dried out for 15 min until it turned white. 
7. Buffer EB (20 µl) was added to resuspend the pellet and elute DNA from the 
silica particles. The tube was incubated at 50 °C for 10 min, followed by 
centrifugation at top speed for 30 seconds. The DNA-containing liquid was 
transferred to a clean Eppendorf tube. 
8. The purified DNA was stored at -20°C, and a small amount of it was checked 
by gel electrophoresis. 
 
F3 Purification of PCR product 
The protocol for purification of PCR product by using QIAquick PCR Purification Kit 
from QIAGEN is described below. 
1. Five volumes of Buffer PB were added to 1 volume of the PCR sample. The 
solution was mixed and then transferred to a QIAquick spin column placed in a 
collection tube. 
2. The sample was centrifuged (13 000 rpm, 1 min) to bind DNA to the column. 
3. The flow-through was removed and Buffer PE (750 µl) was added to wash the 
column. The tube was centrifuged again and the flow-through was discarded. 
One additional centrifugation was performed to remove all traces of washing 
solution. 
4. The column was placed in a clean Eppendorf tube.  
5. The DNA was eluted from the column by adding Buffer EB (50 µl) and 
centrifuging.  
6. The concentration and size of purified DNA was checked by gel 
electrophoresis. Purified DNA was stored at -20 °C. 
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F4 Isolation of plasmid DNA (pDNA) 
The protocol for isolation of pDNA by using Wizard® Plus SV Minipreps DNA 
Purification System from Promega is described below. 
1. The overnight culture was transferred to an Eppendorf tube and centrifuged 
(10 000 rpm, 5 min). The supernatant was discarded and excess media was 
removed by drying the tube on a paper towel. 
2. The cell pellet was resuspended in Cell Resuspension Solution (250 µl). The 
suspension should not be vortexed after step 2 to prevent splitting of 
chromosomal DNA. 
3. Cell Lysis Solution (250 µl) was added and mixed by inverting the tube 4 times. 
The cells were incubated for up to 5 min until the cell suspension cleared, 
which indicated that the cells were lysed. 
4. Alkaline Protease Solution (10 µl) was added to inactivate endonucleases and 
other proteins. Mixed by inverting the tube 4 times, before incubating at room 
temperature for 5 min. (This step is not necessary for a good product and 
Alkaline Protease can in some cases destroy large vectors.) 
5. The suspension was neutralized by adding Neutralization Solution (350 µl), and 
mixed by inverting the tube 4 times, followed by centrifugation (13 000 rpm, 10 
min). 
6. Spin Columns were placed in the Collection Tubes and the DNA-containing 
supernatant was transferred to the Spin Columns. 
7. DNA was bound to the column by centrifugation (13 000 rpm, 1 min), and the 
flow-through was discarded from the Collection Tube. The DNA was washed 
by adding Column Wash Solution (750 µl) to the Spin Column, followed by 
centrifugation (13 000 rpm, 1 min). 
8. The flow-through was discarded and Column Wash Solution (250 µl) was 
added to the Column. The tube was centrifuged again (13 000 rpm, 2 min). 
9. The Spin Column was transferred to a clean Eppendorf tube and Nuclease-Free 
Water (100 µl) was added to elute the DNA bound to the Column. 
10. The Eppendorf tube was centrifuged (13 000 rpm, 1 min) and the purified 
plasmid DNA was stored at -20 °C.  
11. The plasmid size and purity was checked by enzyme digesting, followed by 
DNA gel electrophoresis. 
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ATTACHMENT G: RESULTS FROM UPLC ANALYSIS 
The raw data from measurements of chloramphenicol concentration in three parallel 
samples from each transconjugant strain is presented in Table G1. The number marked 
in red was considered as a statistical outlier and was therefore not included in further 
calculations. 
Table G1: Chloramphenicol concentration in 400 µl of methanol suspension analyzed by UPLC.  
EtOH day Strain Parallel Cml concentration [nM] 
+ 1 c.2 1 218,9 
+ 1 c.2 2 210,7 
+ 1 c.2 3 203,6 
+ 4 c.2 1 311,2 
+ 4 c.2 2 415 
+ 4 c.2 3 396,3 
- 1 c.2 1 47,5 
- 1 c.2 2 46 
- 1 c.2 3 52,4 
- 4 c.2 1 16,5 
- 4 c.2 2 95,6 
- 4 c.2 3 94,3 
+ 1 c.3 1 1484,6 
+ 1 c.3 2 1425,6 
+ 1 c.3 3 1425,7 
+ 4 c.3 1 1763,5 
+ 4 c.3 2 2093,2 
+ 4 c.3 3 2173,5 
- 1 c.3 1 36,9 
- 1 c.3 2 31,3 
- 1 c.3 3 38,9 
- 4 c.3 1 2050 
- 4 c.3 2 2078,8 
- 4 c.3 3 2115,3 
+ 1 c.4 1 453,5 
+ 1 c.4 2 458,5 
+ 1 c.4 3 344,4 
+ 4 c.4 1 521,6 
+ 4 c.4 2 531,7 
+ 4 c.4 3 531,5 
- 1 c.4 1 3863,2 
- 1 c.4 2 4175,8 
- 1 c.4 3 3320,5 
- 4 c.4 1 4717,8 
- 4 c.4 2 4376,9 
- 4 c.4 3 4686,2 
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ATTACHMENT H: RESULTS FROM THE REPORTER ASSAY 
The OD measurements which were performed after 17 hours incubation at room 
temperature (in addition to the first 40 minutes of incubation at 37 °C) are given in 
Table H1-H2. The numbers marked in red were considered as statistical outliers and 
were therefore kept out when calculating the mean and standard deviation of the 
parallels. The negative measurements were set equal to zero, before drawing the 
graphs. Calculation of the mean and standard deviation (SD) was performed by 
standard excel formulas (MEAN and STDAV.S). Standard deviation of the mean was 
calculated by this formula: SD/√   
Table H1: Results from OD405 measurements of the samples collected from recombinant S. 
venezuelae strains with introduced construct 2, 3 and 4. 
EtOH day construct 2 (cmlFp) construct 3(kefBp) construct 4 (noPro) 
+ 1 0,0225 0,0296 0,0375 0,0369 0,0183 0,0203 0,0145 0,0229 - 
+ 4 0,0346 0,0267 0,0346 0,0026 0,0001 0,0129 0,0002 -0,0006 0,0137 
  
 
  
 
    
 
  
  
  
- 1 0,1191 0,0753 0,1118 0,1021 0,1280 0,1122 0,0855 0,0946 0,1109 
- 4 0,1461 0,0395 0,0269 0,1215 0,1206 0,1472 0,0118 0,0234 0,0016 
Blanks: 0,0210 0,0017 
       
Table H2: Results from OD415 measurements of the samples collected from recombinant S. 
venezuelae strains with introduced construct 2, 3 and 4. 
EtOH day construct 2 (cmlFp) construct 3(kefBp) construct 4 (neg. control) 
+ 1 0,0057 0,0170 0,0234 0,0204 0,0017 0,0040 -0,0023 0,0035 - 
+ 4 0,0148 0,0093 0,0148 -0,0137 -0,0163 -0,0063 -0,0145 -0,0170 -0,0026 
  
 
  
  
  
 
    
  - 1 0,0966 0,0523 0,0862 0,0800 0,1065 0,0962 0,0629 0,0750 0,0895 
- 4 0,1216 0,0195 0,0114 0,0980 0,0980 0,1191 -0,0054 0,0058 -0,0144 
Blanks: 0,0073 -0,0073   
       
